Education And Training
Internal Medicine Residency
Department of Internal Medicine, Sunrise Health GME Consortium, Las Vegas, Nevada
07/2025 - 06/2028
Master of Public Health (MPH)
Harvard University, T.H. Chan School of Public Health
08/2026 – 05/2028
M.P.H. Conferral Date: 05/2028
Master of Business Administration (MBA)
The Johns Hopkins University, Carey Business School
01/2025 - 07/2026
M.B.A. Conferral Date: 07/2026
Beta Gamma Sigma (BGS) Honor Society
Doctor of Osteopathic Medicine (DO)
Touro University Nevada
07/2021 - 05/2025
D.O. Conferred: 05/2025
Master of Health Science (MHS)
Touro University Nevada
06/2020 - 06/2021
M.H.S. Conferred: 06/2021
Bachelor of Science (BS)- Human Biology
Utah State University
01/2017 - 05/2020
B.S. Conferred: 05/2020
Cum Laude
High School Diploma
Madison High School, Rexburg, Idaho
Class of 2014
Gpa: 4.0/4.0
Mentors
Dr. Kyaw Zin Thein: Head & Neck, Phase I Trials, Comprehensive Cancer Center of Nevada
Dr. Shivaani Kummar: Early-Phase Clinical Trials; Drug Development; Tumor-Agnostic Therapeutics, Oregon Health & Science University (OHSU)
Dr. Mohamed Shanshal: Thoracic Malignancies; Early-Phase Clinical Trials & Novel Therapeutics Development, Vanderbilt University Medical Center
Dr. Vishisht Mehta: Interventional Pulmonologist, Comprehensive Cancer Center of Nevada
Oncology Honors And Awards
2026 Conquer Cancer Merit Award
ASCO Quality Care Symposium, American Society of Clinical Oncology. Awarded for the abstract “The Oncology Capability Gap: Failure-to-Rescue Following High-Risk Oncologic Emergencies in the United States” (Abstract No. 525). August 2026.
American Society of Clinical Oncology (ASCO) Early-Onset/Adolescent and Young Adult (EO/AYA) Research Shoutout
American Society of Clinical Oncology. Inpatient Burden and Outcomes Across Gastrointestinal Cancer Subtypes Among Younger Adults in the United States, 2018-2022.” J Clin Oncol. https://doi.org/10.1200/JCO.2026.44.16_suppl.11077
2026 Outstanding Author, Translational Breast Cancer Research (TBCR)
AME Publishing Company. Recognized as a 2026 Outstanding Author by Translational Breast Cancer Research (TBCR). August 2026. https://tbcr.amegroups.org/post/view/interviews-with-outstanding-authors-2026
Research Overview
Manuscripts, abstracts, case reports, and presentations are reported separately. Categories overlap and are not a combined publication total.
Full Papers (3)
Exploration of Targeted Anti-tumor Therapy (ETAT)- (Impact Factor: 2.59)
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Nanda RK, Ta J, Tzer-Ming Chuang B, Myat YM, Hanspal A, Thein KZ, Htut TW. A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials to Assess the Risk of Pneumonia, URTIs, and VTE in Multiple Myeloma Patients Treated with Isatuximab. Exploration of Targeted Anti-Tumor Therapy (ETAT). March 19, 2025. Publication Status: Published. Article URL: https://doi.org/10.37349/etat.2025.1002300
Addition of Immune Checkpoint Inhibitor to Standard of Care Chemoradiotherapy in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
Oncology Research – (Impact Factor: 4.2)
Jones DT, Sangha T, Manjikian A, Ghobrial M, Shawesh Q, Tiwana E, Hearn E, Latif A, Tupas E, Hanspal A, Nanda RK, Srinivasmurthy R, Ta J, Pandit M, Larson CAJ, Thein KZ. Toxicities of Fruquintinib in Gastrointestinal Malignancies: Evidence From Randomized Trials. Oncology Research. 2026. Publication Status: Accepted. Article URL: https://doi.org/10.32604/or.2026.078524
Cancers – (Impact Factor: 4.4)
Srinivasmurthy R, Jones DT, Nanda RK, Ta J, Hussain A, Hattin R, Tian S, Shah S, Bigcas JL, Wang R, Francis S, Thein KZ. Biomarker-Stratified Efficacy of Immune Checkpoint Inhibitors in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Randomized Trials. Cancers. 2026;18(11):1679. Publication Status: Published. Article URL: https://doi.org/10.3390/cancers18111679
Review Articles (8)
Cancers – (Impact Factor: 4.4)
Jones DT, Nanda RK, Hussain AA, Hattin R, Myat YM, Thawani R, Cetnar J, Shanshal M, Thein KZ, Kummar S. Evaluating Tissue-Agnostic Approvals in Thoracic and Head and Neck Malignancies. Cancers. 2026. Publication Status: Published. Article URL: https://doi.org/10.3390/cancers18050856
Translational Breast Cancer Research (TBCR) – (Impact Factor: 1.4)
Jones DT, Nanda RK, Dhillon M, Hanspal A, Makhdoom EN, Ta J, Srinivasmurthy R, Hussain AA, Hattin R, Vu T, Myat YM, Aboaid H, Thein KZ. Tumor-Agnostic Therapies in Breast Cancer: Evidence and Gaps Across Nine FDA Approvals. Translational Breast Cancer Research. 2025. Publication Status: Accepted. Article URL: https://doi.org/10.21037/tbcr-2025-1-69
Frontiers in Oncology – (Impact Factor: 6.24)-
Aboaid H, Khalid T, Hussain A, Myat YM, Nanda RK, Srinivasmurthy R, Nguyen K, Jones DT, Bigcas JL, Thein KZ. Advances & Challenges in Immunotherapy in Head and Neck Cancer. Frontiers in Oncology. 2025. Publication Status: Published. Article URL: https://doi.org/10.3389/fimmu.2025.1596583
Hussain A, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Myat YM, Hattin R, Bigcas JL, Tian S, Shah S, Wang R, Thein KZ. Resistance Mechanisms in Immunotherapy-Radiotherapy/Chemotherapy Combinations in Locally Advanced Head & Neck Squamous Cell Carcinoma. Oncology Research. 2026. Publication Status: Published Online. Article URL: https://doi.org/10.32604/or.2026.077918
Translational Cancer Research – (Impact Factor: 1.5)-
Aboaid H, Myat YM, Jones DT, Thein KZ. Trastuzumab Deruxtecan: Expanding the Role of HER2-Targeted Therapy in Solid Tumors. Transl Cancer Res. 2025. Publication Status: Published. Article URL: https://tcr.amegroups.org/article/view/101299
Oncology Research – (Impact Factor: 4.1)
Rubinstein M, Hong M, Nanda R, Jones DT, Aboid H, Myat Y, Thein KZ. Advances in Tissue-agnostic Targeting in Cancer Therapeutics: Current Approvals, Challenges, and Future Directions. Oncology Research. 2025. Publication Status: Published. Article URL: https://doi.org/10.32604/or.2025.067791
Onco – (Impact Factor: 0)
Sajid S, Abdullah MD, Hanspal A, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Gemil H, Thein KZ. Rethinking Immunotherapy Drug Development in Head and Neck Squamous Cell Carcinoma: The Role of Biologic Context and Treatment Sequencing. Onco. 2026. Publication Status: Under Peer Review. Article URL: https://doi.org/10.3390/onco6030037
Cardiology in Review – (Impact Factor: 2.0)
Mohammadi A, Jones DT, Mohammadi S, Frishman WH, Aronow WS. Telomere Dynamics in Cardiovascular Aging: From Molecular Mechanisms to Precision Medicine. Cardiol Rev. August 2025. Publication Status: Published. Article URL: https://journals.lww.com/cardiologyinreview/abstract/9900/telomere_dynamics_in_cardiovascular_aging__from.565.aspx
Abstracts (246)
American Society of Hematology (ASH) 2024 – Blood Journal (Impact Factor: 21.0)
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Nanda RK, Thein KZ, Htut TW.. Updated Meta-Analysis of Phase III Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Pneumonia, Upper Respiratory Tract Infections (URTIs) and Venous Thromboembolism (VTE) in Patients with Multiple Myeloma Treated with Isatuximab. American Society of Hematology (ASH). July 2024. Publication Status: Published. Article URL: https://doi.org/10.1182/blood-2024-211295
Aboaid H, Jones DT, Srinivasmurthy R, Nguyen K, Nanda RK, Thein KZ, Htut TW.. Updated Meta-Analysis of Phase III Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Second Primary Malignancies (SPMs) in Patients with Multiple Myeloma (MM) Treated with Isatuximab. American Society of Hematology (ASH). July 2024. Publication Status: Published. Article URL: https://doi.org/10.1182/blood-2024-211236
Aboaid H, Srinivasmurthy R, Jones DT, Nguyen K, Nanda RK, Thein KZ, Htut TW.. Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. American Society of Hematology (ASH). July 2024. Publication Status: Published. Article URL: https://doi.org/10.1182/blood-2024-209018
American Society of Hematology (ASH) 2025 - Blood (Impact Factor: 21.0)
Hussain A, Jones DT, Ta J, Srinivasmurthy R, Nanda RK, Hattin R, Winland L, Karamian P, Joseph Y, Mohib K, Win ZT, Tun T, Dhillon M, Thein KZ, Htut TW. Incidence of Cardiac Toxicities in Patients with Hematologic Malignancies Treated with Zanubrutinib Compared to Control, including BTK Inhibitor (Ibrutinib): A Meta-Analysis of Randomized Controlled Trials. American Society of Hematology (ASH). December 2025. Publication Status: Pending Publication. Article URL: https://doi.org/10.1182/blood-2025-4554
Ta J, Hussain A, Jones DT, Srinivasmurthy R, Nanda RK, Hattin R, Khalid A, Ahmad S, Afifi S, Win ZT, Tun T, Dhillon M, Thein KZ, Htut TW. Incidence of Bleeding and Hypertension in Patients with Hematologic Malignancies Treated with Next-Generation Bruton Tyrosine Kinase (BTK) Inhibitors: A Meta-Analysis of Randomized Controlled Trials. American Society of Hematology (ASH). December 2025. Publication Status: Pending Publication. Article URL: https://doi.org/10.1182/blood-2025-2739
Nanda RK, Jones DT, Srinivasmurthy R, Ta J, Hussain A, Hattin R, Winland L, Karamian P, Joseph Y, Mohib K, Myat YM, Tun T, Dhillon M, Thein KZ, Htut TW. Incidence of Second Primary Malignancies in Patients with Hematologic Malignancies Treated with Next-Generation Bruton Tyrosine Kinase (BTK) Inhibitors: A Meta-Analysis of Randomized Controlled Trials. American Society of Hematology (ASH). December 2025. Publication Status: Pending Publication. Article URL: https://doi.org/10.1182/blood-2025-4552
Srinivasmurthy R, Hussain A, Nanda RK, Jones DT, Ta J, Hattin R, Khalid A, Ahmad S, Afifi S, Win ZT, Tun T, Dhillon M, Thein KZ, Htut TW. Incidence of Cardiac Events Associated with Next-Generation Bruton Tyrosine Kinase (BTK) Inhibitors Compared to Control in Hematologic Malignancies: A Meta-Analysis of Randomized Trials. American Society of Hematology (ASH). December 2025. Publication Status: Pending Publication. Article URL: https://doi.org/10.1182/blood-2025-8067
American Society of Hematology (ASH) 2026 - Blood (Impact Factor: 21.0)
Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Makhdoom E, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Persistent High-Acuity Inpatient Burden of Blastic Plasmacytoid Dendritic Cell Neoplasm in the Contemporary Treatment Era: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Makhdoom E, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Transfusion-Associated Circulatory Overload in Myelodysplastic Syndromes: National Mortality, Cardiopulmonary Complications, and Resource Utilization. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Efendi A, Lwin S, Hsu J, Larson CAJ, Nanda RK, Jones DT, Ho L, Thein KZ. Concurrent Hypercalcemia and Sepsis Define a High-Risk Inpatient Phenotype in Adult T-Cell Leukemia/Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Efendi A, Lwin S, Hsu J, Larson CAJ, Nanda RK, Jones DT, Ho L, Thein KZ. Unusual-Site Venous Thrombosis in Myeloproliferative Neoplasms: National Outcomes of Splanchnic and Cerebral Venous Events. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hanspal A, Sajid S, Vu T, Dhillon M, Makhdoom E, Upreti S, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Autoimmune Cytopenias Define Distinct Bleeding and Multiorgan-Failure Phenotypes in Angioimmunoblastic T-Cell Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hanspal A, Sajid S, Vu T, Dhillon M, Makhdoom E, Upreti S, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Down Syndrome and Inpatient Outcomes in Acute Lymphoblastic Leukemia: A National Analysis of Multisystem Toxicity and Critical Illness. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hanspal A, Sajid S, Vu T, Dhillon M, Makhdoom E, Upreti S, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Severe Infection Drives Inpatient Mortality and Organ Failure in T-Cell Prolymphocytic Leukemia: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hattin R, Hussain AA, Srinivasmurthy R, Larson CAJ, Nanda RK, Hsu J, Ta J, Jones DT, Thein KZ. Anatomic Phenotypes of Thrombosis in Paroxysmal Nocturnal Hemoglobinuria: National Inpatient Outcomes and Resource Utilization, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hattin R, Hussain AA, Srinivasmurthy R, Larson CAJ, Nanda RK, Hsu J, Ta J, Jones DT, Thein KZ. Perforation and Hemorrhage Define a High-Risk Inpatient Phenotype in Enteropathy-Associated T-Cell Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hsu J, Larson CAJ, Nanda RK, Jones DT, Thein KZ. In-Hospital Outcomes and Resource Utilization Associated With Inter-Hospital Transfer During Acute Leukemia Emergencies. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hsu J, Larson CAJ, Nanda RK, Jones DT, Thein KZ. Inpatient Outcomes of Concurrent Thrombosis and Major Bleeding in Myeloproliferative Neoplasm Hospitalizations. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Htun AMM, Parke JK, Pi B, Taysom C, Larson CAJ, Nanda RK, Srinivasmurthy R, Hattin R, Ta J, Hussain AA, Jones DT, Thein KZ. Critical Care Escalation in Acute Leukemia: National Variation in Mechanical Ventilation, Dialysis, and Conditional Mortality. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Htun AMM, Parke JK, Pi B, Taysom C, Larson CAJ, Nanda RK, Srinivasmurthy R, Hattin R, Ta J, Hussain AA, Jones DT, Thein KZ. Respiratory Syncytial Virus, Influenza, and SARS-CoV-2 in Hematologic Malignancy: National Inpatient Mortality and Respiratory Severity, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hussain A, Srinivasmurthy R, Larson CAJ, Nanda RK, Hsu J, Ta J, Hattin R, Jones DT, Thein KZ. Presentation-Associated Versus Treatment-Context Tumor Lysis Syndrome: National Mortality, Renal Failure, and Critical-Illness Burden. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Hussain AA, Nanda RK, Fonseca RR, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Safety of Intensive Early Treatment Strategies for High-Risk Smoldering Multiple Myeloma: A Systematic Review of Prospective Clinical Studies. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Jones DT, Larson CAJ, Nanda RK, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Graded Cytokine Release Syndrome Across Hematologic Malignancies: National Mortality and Critical-Care Burden in the Immune-Effector Therapy Era. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Jones DT, Larson CAJ, Nanda RK, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Pathogen-Specific Mortality, Critical Illness, and Economic Burden of Invasive Fungal Infections in Acute Myeloid Leukemia. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Kanwal HI, Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Oshiro C, Vu A, Nanda RK, Jones DT, Thein KZ. Contemporary Inpatient Phenotypes of Hereditary Hemorrhagic Telangiectasia: National Bleeding, Visceral, and Multiorgan Outcomes. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Kanwal HI, Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Oshiro C, Vu A, Nanda RK, Jones DT, Thein KZ. Sepsis Without Cellulitis Identifies the Highest-Risk Inpatient Phenotype in Cutaneous T-Cell Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Larson CAJ, Nanda RK, Fonseca RR, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Efficacy and Safety of Venetoclax-Based Therapy in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Studies. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Larson CAJ, Nanda RK, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Jones DT, Thein KZ. Disseminated Intravascular Coagulation, Rather Than Thrombocytopenia, Identifies the Highest-Risk Phenotype Among Hospitalizations With Acute Myeloid Leukemia and Intracranial Hemorrhage. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Larson CAJ, Nanda RK, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Jones DT, Thein KZ. Hemophagocytic Lymphohistiocytosis Identifies a High-Mortality Multiorgan Failure Phenotype in Peripheral T-Cell Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Lin WJ, Win ZT, Larson CAJ, Nanda RK, Chovatiya J, Jones DT, Htwe KK, Yang EH, Thein KZ. Infection and Intercurrent Illness Drive the Inpatient Burden of Cutaneous Follicle Center Lymphoma: A National Analysis, 2016 to 2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Lin WJ, Win ZT, Larson CAJ, Nanda RK, Chovatiya J, Jones DT, Htwe KK, Yang EH, Thein KZ. National Burden of Serious Infection and Organ Failure in Hemoglobin E-Beta Thalassemia, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Lwin S, Efendi A, Hsu J, Larson CAJ, Nanda RK, Jones DT, Ho L, Thein KZ. Hospital Teaching Status and In-Hospital Mortality Across Adult Leukemia Subtypes: A National Interaction Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Lwin S, Efendi A, Hsu J, Larson CAJ, Nanda RK, Jones DT, Ho L, Thein KZ. The Arterial-Venous Thrombosis Intersection in Cold Autoimmune Hemolytic Anemia: National Inpatient Outcomes, 2021-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Greater Complication Burden but Comparable In-Hospital Mortality at Urban Teaching Hospitals in Acute Promyelocytic Leukemia: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Sepsis Overrides ALK-Defined Prognostic Differences in Systemic Anaplastic Large Cell Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Fonseca RR, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Clinical Outcomes of Frontline Lower-Intensity Venetoclax-Based Therapy in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Studies. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Fonseca RR, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Clinical Outcomes of Intensive Therapy in High-Risk Smoldering Multiple Myeloma: A Systematic Review and Meta-Analysis of Prospective Studies. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Fonseca RR, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Concurrent Malignancy and Serious Infection Define a High-Mortality Phenotype in Adult Hemophagocytic Lymphohistiocytosis: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Fonseca RR, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Concurrent Thrombosis and Acute Kidney Injury Define a High-Risk Inpatient Phenotype in Cold Autoimmune Hemolytic Anemia. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Fonseca RR, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Concurrent Tumor Lysis Syndrome and Acute Kidney Injury Define a High-Risk Inpatient Phenotype in Burkitt Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Fonseca RR, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Early Treatment Versus Observation in High-Risk Smoldering Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Grade 4 Cytokine Release Syndrome Defines a High-Risk Critical-Care Phenotype in Patients With Hematologic Malignancies: A National Inpatient Analysis. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Nanda RK, Larson CAJ, Hsu J, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Jones DT, Thein KZ. Heart Failure Hospitalizations Among Leukemia and Lymphoma Survivors: National Outcomes and Cardiogenic Shock Severity, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Oshiro C, Kanwal HI, Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Vu A, Nanda RK, Jones DT, Thein KZ. Acute Kidney Injury Defines a Severity-Dependent Mortality and Multiorgan-Failure Phenotype in Sezary Syndrome: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Oshiro C, Kanwal HI, Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Vu A, Nanda RK, Jones DT, Thein KZ. Acute Organ Failure and Malnutrition Define High-Risk Inpatient Phenotypes in MALT Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Parke JK, Pi B, Htun AMM, Taysom C, Larson CAJ, Nanda RK, Srinivasmurthy R, Hattin R, Ta J, Hussain AA, Jones DT, Thein KZ. Severe Multisystem Castleman Disease Hospitalizations in the United States: National Outcomes and Resource Utilization, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Pi B, Htun AMM, Parke JK, Taysom C, Larson CAJ, Nanda RK, Srinivasmurthy R, Hattin R, Ta J, Hussain AA, Jones DT, Thein KZ. National Treatment Patterns and Outcomes of Hematologic Malignancy-Associated Spinal Cord Compression: A Comparison of Multiple Myeloma and Lymphoma, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Sajid S, Hanspal A, Vu T, Dhillon M, Makhdoom E, Upreti S, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Arterial Occlusive Events in Chronic Myeloid Leukemia: National Outcomes of Myocardial Infarction, Ischemic Stroke, and Acute Limb Ischemia. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Sangha T, Hanspal A, Manjikian A, Tiwana E, Hearn E, Latifi A, Tupas E, Ghobrial M, Shawesh Q, Brown LM, Kashani M, Bakir R, Nanda RK, Jones DT, Thein KZ. Concurrent Sepsis and Major Bowel Complications Define a High-Risk Inpatient Phenotype in Acute Leukemia-Associated Neutropenic Enterocolitis. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Sangha T, Hanspal A, Manjikian A, Tiwana E, Hearn E, Latifi A, Tupas E, Ghobrial M, Shawesh Q, Brown LM, Kashani M, Bakir R, Nanda RK, Jones DT, Thein KZ. Concurrent Sepsis and Multiorgan Dysfunction Define a High-Risk Phenotype in Acute Pancreatitis Among Adults With Acute Leukemia. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Srinivasmurthy R, Larson CAJ, Nanda RK, Hsu J, Ta J, Hussain AA, Hattin R, Jones DT, Thein KZ. Acute Neurologic Complications in Acute Lymphoblastic Leukemia: National Outcomes of Cerebral Venous Sinus Thrombosis, Posterior Reversible Encephalopathy Syndrome, and Stroke. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Srinivasmurthy R, Larson CAJ, Nanda RK, Hsu J, Ta J, Hussain AA, Hattin R, Jones DT, Thein KZ. Platelet Transfusion Without a Major Indication in Immune Thrombocytopenia: National Trends and Resource Burden After 2019. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Ta J, Hattin R, Hussain AA, Srinivasmurthy R, Larson CAJ, Nanda RK, Hsu J, Jones DT, Thein KZ. Concurrent Acute Thrombosis and Multiorgan Failure Identify a High-Mortality CAPS-Like Phenotype in Antiphospholipid Syndrome: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Ta J, Hattin R, Hussain AA, Srinivasmurthy R, Larson CAJ, Nanda RK, Hsu J, Jones DT, Thein KZ. The Thrombotic-Bleeding Paradox in Heparin-Induced Thrombocytopenia: National Mortality, Critical-Illness, and Limb-Loss Burden. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Taysom C, Larson CAJ, Nanda RK, Srinivasmurthy R, Hattin R, Ta J, Hussain AA, Jones DT, Thein KZ. Acute Kidney Injury Identifies a High-Risk Renal Phenotype in Monoclonal Gammopathy Without Overt Plasma-Cell Malignancy: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Taysom C, Larson CAJ, Nanda RK, Srinivasmurthy R, Hattin R, Ta J, Hussain AA, Jones DT, Thein KZ. Administrative Plasma-Cell Disorder Severity Phenotypes and Inpatient Outcomes: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Upreti S, Hanspal A, Sajid S, Vu T, Dhillon M, Makhdoom E, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Concurrent Diffuse Large B-Cell Lymphoma Coding Identifies a High-Risk Transformation-Associated Phenotype in Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A National Inpatient Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Upreti S, Hanspal A, Sajid S, Vu T, Dhillon M, Makhdoom E, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. The Autoimmune Cytopenia Spectrum in Chronic Lymphocytic Leukemia: National Outcomes of Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Concurrent Disease. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Vu A, Oshiro C, Kanwal HI, Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Nanda RK, Jones DT, Thein KZ. Concurrent Major Bleeding and Serious Infection Define a High-Burden Critical-Illness Phenotype in Acquired Hemophilia: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Vu A, Oshiro C, Kanwal HI, Makhdoom E, Dhillon M, Vu T, Upreti S, Hanspal A, Sajid S, Nanda RK, Jones DT, Thein KZ. The Bleeding-Thrombosis Paradox in Acquired Hemophilia: Mortality Across Discordant Hemostatic Phenotypes. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Vu T, Upreti S, Hanspal A, Sajid S, Dhillon M, Makhdoom E, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Acute Neurologic Complications Define a High-Risk Inpatient Phenotype in Waldenstrom Macroglobulinemia: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Vu T, Upreti S, Hanspal A, Sajid S, Dhillon M, Makhdoom E, Oshiro C, Kanwal HI, Vu A, Nanda RK, Jones DT, Thein KZ. Sepsis as a Dominant Determinant of Inpatient Mortality and Multiorgan Failure in Hepatosplenic T-Cell Lymphoma: A National Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Win ZT, Larson CAJ, Nanda RK, Chovatiya J, Lin WJ, Jones DT, Htwe KK, Yang EH, Thein KZ. Cardiac Severity and Admission Phenotypes in Light-Chain Amyloidosis: National Mortality, Critical-Illness, and Resource Burden. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
Win ZT, Larson CAJ, Nanda RK, Chovatiya J, Lin WJ, Jones DT, Htwe KK, Yang EH, Thein KZ. Concurrent Anemia and Acute Cardiac Complications Define a High-Risk Cardiorenal Phenotype in Waldenstrom Macroglobulinemia: A National Inpatient Analysis, 2016-2023. American Society of Hematology (ASH). August 2026. Publication Status: Accepted. Article URL:
American Society of Clinical Oncology (ASCO) 2025 – Journal of Clinical Oncology (Impact Factor: 45.3)
Aboaid H, Khalid T, Jones DT, Nanda RK, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Efficacy of definitive radiotherapy with concurrent and adjuvant immune checkpoint inhibitors in patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). May 2025. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.6062
Aboaid H, Hussain A, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ. Incidence of venous thromboembolism (VTE) events in patients with EGFR-mutant non-small cell lung cancer (NSCLC) treated with Amivantamab: A systematic review and combined meta-analysis of phase 3 randomized controlled trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). May 2025. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.12042
Hattin R, Aboaid H, Jones DT, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Srinivasmurthy R, Thein KZ, Htut TW. Incidence of ocular toxicities in patients with relapsed/refractory multiple myeloma treated with Belantamab Mafodotin: A systematic review and meta-analysis of phase 3 randomized controlled trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). May 2025. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.12040
Hussain A, Aboaid H, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ. Risk of pulmonary toxicities in patients with EGFR-mutant non-small cell lung cancer (NSCLC) treated with Amivantamab: A systematic review and meta-analysis of phase 3 randomized controlled trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). May 2025. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.e24035
American Society of Clinical Oncology (ASCO) 2026 – Journal of Clinical Oncology (Impact Factor: 45.3)
Jones DT, Nanda RK, Thein KZ, Thawani R, Kummar S. Cachexia as an inpatient vulnerability phenotype in lung cancer: A National Inpatient analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23225
Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Hattin R, Hussain A, Thein KZ, Behl D, Leventakos K, Shanshal M. Emergency vs elective presentation as a care-delivery phenotype in presumed early-stage lung cancer: A National Inpatient analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23223
Larson CAJ, Srinivasmurthy R, Nanda RK, Ta J, Jones DT, Thein KZ. Failure-to-rescue following major surgical complications in gynecologic oncology: A National Inpatient analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23124
Larson CAJ, Srinivasmurthy R, Nanda RK, Ta J, Jones DT, Thein KZ. Malnutrition and cachexia as drivers of failure-to-rescue in gynecologic cancer hospitalizations, 2016–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11053
Rankine S, Ta J, Srinivasmurthy R, Nanda RK, Mirza M, Larson CAJ, Jones DT, Thein KZ. National characteristics of Kaposi sarcoma–related hospitalizations and in-hospital outcomes in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23529
Rankine S, Ta J, Srinivasmurthy R, Nanda RK, Mirza M, Larson CAJ, Jones DT, Thein KZ. National patterns of hospitalization, mortality, and resource utilization in Merkel cell carcinoma in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e21574
Mirza M, Ta J, Srinivasmurthy R, Nanda RK, Rankine S, Jones DT, Thein KZ, Larson CAJ. National trends in melanoma-related hospitalizations, admission characteristics, and in-hospital outcomes in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e21573
Mirza M, Ta J, Srinivasmurthy R, Nanda RK, Rankine S, Larson CAJ, Jones DT, Thein KZ. National trends in non-melanoma skin cancer–related hospitalizations and in-hospital outcomes in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e21552
Peterson S, Nanda RK, Larson CAJ, Ta J, Srinivasmurthy R, Thein KZ, Jones DT. Shifting drivers of hospitalization in endometrial cancer: Toxicity-like organ failure phenotypes in the modern treatment era. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11066
Peterson S, Nanda RK, Larson CAJ, Ta J, Srinivasmurthy R, Thein KZ, Jones DT. The diagnostic delay signature in rare gynecologic cancers: Assessment of emergency presentation, acute organ failure, and failure-to-rescue. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23143
Chander C, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Larson CAJ, Jones DT, Thein KZ. Failure-to-rescue after major complications in endometrial cancer: A National Inpatient analysis (NIS, 2016–2023). American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e17637
Chander C, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Larson CAJ, Jones DT, Thein KZ. Emergency presentation as a diagnostic failure phenotype in ovarian cancer: A National Inpatient analysis (NIS 2016–2023). American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e17575
Win ZT, Srinivasmurthy R, Nanda RK, Ta J, Hattin R, Hussain A, Larson CAJ, Ardeshna-Chovatiya J, Lin WJ, Jones DT, Thein KZ, Yang EH. Atrial fibrillation as a sentinel cardiovascular event in renal cell carcinoma hospitalizations: National Inpatient outcomes and rescue failure (NIS 2016–2023). American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23226
Srinivasmurthy R, Hussain A, Nanda RK, Jones DT, Ta J, Hattin R, Tian S, Shah S, Bigcas JL, Wang R, Francis S, Thein KZ. Impact of PD-L1 and HPV biomarkers on immune checkpoint inhibitor efficacy in locally advanced HNSCC: A systematic review of randomized trials. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e18050
Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Larson CAJ, Jones DT, Thein KZ. Terminal admission phenotype in acute myeloid leukemia: A national analysis of inpatient care intensity (NIS 2016–2023). American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23207
Hattin R, Nanda RK, Hussain A, Jones DT, Srinivasmurthy R, Ta J, Tian S, Bigcas JL, Wang R, Francis S, Thein KZ. Adverse effects associated with immune checkpoint inhibitors in locally advanced nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e18105
Hattin R, Hussain A, Srinivasmurthy R, Nanda RK, Ta J, Jones DT, Thein KZ, Behi D, Leventakos K, Shanshal M. Inpatient chemotherapy in small cell lung cancer as a high-risk care-delivery phenotype: National Inpatient Sample analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23193
Hussain A, Srinivasmurthy R, Nanda RK, Ta J, Mohib K, Khalid A, Larson CAJ, Hattin R, Jones DT, Thein KZ. Hospital-acquired sepsis as a driver of failure-to-rescue in AML and MDS: A national inpatient sample analysis, 2016–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23219
Hussain A, Mohib K, Jones DT, Nanda RK, Ta J, Srinivasmurthy R, Hattin R, Tian S, Shah S, Bigcas JL, Wang R, Francis S, Thein KZ. The impact of surgery and the type of immune check point inhibitors (ICI) in patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC) receiving immunotherapy: An updated systematic review and meta-analysis of randomized controlled trials. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e18081
Lee D, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Larson CAJ, Jones DT, Thein KZ. Association of pre-existing chronic kidney disease with in-hospital mortality and resource utilization among U.S. solid tumor hospitalizations: A National Inpatient Sample analysis, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23166
Lee D, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Larson CAJ, Jones DT, Thein KZ. Heart failure in hospitalizations for hematologic malignancies versus solid tumors: National burden and inpatient outcomes, 2018-2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11074
Taysom C, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Jones DT, Thein KZ. Association of acute kidney injury with in-hospital mortality and resource utilization among U.S. solid tumor hospitalizations: A National Inpatient Sample analysis, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23163
Taysom C, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Jones DT, Thein KZ. Electrolyte abnormalities and arrhythmia-associated inpatient deterioration in hospitalized cancer patients: National patterns in the National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23162
Lin WJ, Nanda RK, Jones DT, Thein KZ, Kummar S, Thawani R. Emergency presentation and inpatient vulnerability in sinonasal malignancies: National evidence of a diagnostic delay phenotype. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23248
Lin WJ, Srinivasmurthy R, Nanda RK, Ta J, Hattin R, Hussain A, Larson CAJ, Jones DT, Thein KZ. Hidden advanced physiology in non-metastatic gastrointestinal cancer: Malnutrition/cachexia and in-patient failure-to-rescue. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11102
Nanda RK, Jones DT, Srinivasmurthy R, Hussain A, Hattin R, Ta J, Tian S, Bigcas JL, Shah S, Wang R, Francis S, Thein KZ. Adverse effects of immune checkpoint inhibitors in locally advanced head and neck squamous cell carcinoma: A meta-analysis of randomized trials. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e24179
Nanda RK, Jones DT, Thein KZ, Potter A, Sener U, Zadeh G, Shanshal M. Efficacy and safety of intrathecal chemotherapy in EGFR-mutant non–small cell lung cancer with leptomeningeal metastases: A systematic review and meta-analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e20700
Ta J, Srinivasmurthy R, Jones DT, Nanda RK, Hussain A, Hattin R, Francis S, Shah S, Bigcas JL, Wang R, Tian S, Thein KZ. Efficacy of immune checkpoint inhibitors (ICIs) in locoregionally advanced nasopharyngeal carcinoma (LA NPC): A meta-analysis of phase II and III randomized controlled trials. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e18068
Sajid S, Abdullah MD, Jones DT, Haddadin R, Thein KZ, Ahmed B. Real-world outcomes of immune checkpoint inhibitors in patients aged 65–74 versus ≥75 years with non-small cell lung cancer. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e20642
Sajid S, Vu T, Abdullah MD, Jones DT, Thein KZ, Shah P. Cardiotoxicity diagnoses and inpatient outcomes in principal breast cancer hospitalizations: National Inpatient Sample, 2018–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e24036
Abdullah MD, Sajid S, Jones DT, Hanspal A, Thein KZ, Ahmed B. Care utilization and inpatient mortality among women younger than 50 years hospitalized with breast cancer: Racial and socioeconomic disparities. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e13757
Abdullah MD, Sajid S, Jones DT, Haddadin R, Thein KZ, Ahmed B. Age-stratified outcomes of immune checkpoint inhibitors in geriatric patients with melanoma: A real-world cohort study. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e13779
Hanspal A, Sangha T, Manjikian A, Dhillon M, Vu T, Jones DT, Thein KZ, Sheraz F. Malnutrition as a hidden driver of inpatient mortality in gastrointestinal cancer: A national analysis of the U.S. National Inpatient Sample, 2016–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23235
Hanspal A, Sangha T, Manjikian A, Dhillon M, Jones DT, Abdullah MD, Thein KZ, Sheraz F, Upreti S. Terminal admission phenotypes and inpatient mortality in gastrointestinal malignancies: A national analysis of U.S. hospitalizations, 2018–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23231
Dhillon M, Hanspal A, Vu T, Jones DT, Thein KZ, Rahman F. Frailty phenotypes and acute care escalation in hospitalized patients with solid tumors: A National Inpatient Sample analysis, 2016–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23202
Dhillon M, Hanspal A, Vu T, Jones DT, Thein KZ, Rahman F. Dysphagia-associated inpatient risk phenotypes and mortality in hospitalized head and neck cancer: A national analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11085
Vu T, Dhillon M, Jones DT, Hanspal A, Sajid S, Thein KZ, Shetty K. Treatment-interrupting hospitalization as an acute oncologic toxicity in solid tumors. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23204
Upreti S, Makhdoom E, Hanspal A, Jones DT, Sheraz F, Thein KZ, Vu T. Racial and payer-based disparities in inpatient resource utilization and mortality among patients hospitalized with head and neck cancer in the United States, 2018 to 2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11099
Upreti S, Hanspal A, Makhdoom E, Jones DT, Thein KZ, Sheraz F. National trends in inpatient incidence of head and neck cancer and anatomic subsites in the United States, 2018 to 2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23233
Makhdoom E, Jones DT, Vu T, Upreti S, Rahman F, Thein KZ. HPV-enriched oropharyngeal head and neck cancer and inpatient outcomes: A national analysis of U.S. hospitalizations, 2016 to 2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23173
Makhdoom E, Jones DT, Upreti S, Vu T, Rahman F, Thein KZ. Malnutrition as associated with high-risk airway failure phenotypes in hospitalized head and neck cancer: A national, site-specific analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23172
Aboujaoude C, Chattha S, Singtong B, Jones DT, Shah P, Thein KZ. Atrial fibrillation as an acute severity amplifier during cancer hospitalizations: A National Inpatient Sample analysis, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23098
Aboujaoude C, Chattha S, Singtong B, Jones DT, Shah P, Thein KZ. Venous thromboembolism as a trigger for acute cardiac decompensation during cancer hospitalizations: A National Inpatient Sample analysis, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23099
Chattha S, Aboujaoude C, Singtong B, Jones DT, Thein KZ, Rahman F. Failure-to-rescue after acute cardiac events in cancer versus non-cancer hospitalizations. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23241
Tabbah T, Pathiranage T, Aboujaoude C, Chattha S, Jones DT, Thein KZ, Shah P. Cancer-associated bradyarrhythmias and inpatient deterioration in U.S. hospitalizations. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23107
Hassan KM, Seifert G, Hashmi M, Jones DT, Thein KZ, Sheraz F. Right-sided circulatory failure without pulmonary embolism in hospitalized cancer patients: National burden and inpatient outcomes. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e24033
Seifert G, Hassan KM, Hashmi M, Jones DT, Thein KZ, Shah P. Cancer-associated left ventricular thrombus in hospitalized oncology patients: National burden and inpatient outcomes. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23230
Seifert G, Hassan KM, Hashmi M, Jones DT, Thein KZ, Shah P. Cancer-associated type 2 versus type 1 myocardial infarction: A physiology-driven framework for inpatient risk stratification. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23234
Krason B, Shergill S, Jones DT, Thein KZ, Rahman F. Cancer-associated myocarditis outside of immunotherapy: National burden and inpatient outcomes in the National Inpatient Sample, 2018–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23218
Shergill S, Krason B, Jones DT, Thein KZ, Sheraz F. Cardiac complications as a major driver of ICU utilization in hospitalized cancer patients: A National Inpatient Sample analysis, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23167
Sangha T, Hanspal A, Manjikian A, Jones DT, Lenhart L, Sheraz F, Selleck M, Thein KZ. Failure-to-rescue after pancreatectomy for pancreatic cancer in the United States: National Inpatient outcomes, 2018–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23232
Sangha T, Hanspal A, Manjikian A, Jones DT, Thein KZ, Sheraz F. Trends in toxicity-associated hospitalizations and inpatient outcomes among gastrointestinal malignancies in the United States, 2016–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23237
Manjikian A, Sangha T, Hanspal A, Jones DT, Sheraz F, Thein KZ. Failure-to-rescue following acute hepatic decompensation in hospitalized patients with hepatocellular carcinoma in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23119
Manjikian A, Sangha T, Hanspal A, Jones DT, Sheraz F, Thein KZ. Failure-to-rescue after acute complications in gastrointestinal cancer hospitalizations in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23118
Shawesh Q, Tiwana E, Hearn E, Latifi A, Jones DT, Thein KZ, Sheraz F. Admission acuity and inpatient outcomes among hospitalizations for pancreatic cancer in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e16352
Shawesh Q, Manjikian A, Sangha T, Tiwana E, Latifi A, Ghobrial M, Tupas E, Hearn E, Hanspal A, Jones DT, Thein KZ, Shah P. Inpatient Mortality Across Gastrointestinal Malignancies by Hospital Structural Characteristics in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e16353
Tiwana E, Jones DT, Hearn E, Shawesh Q, Sheraz F, Thein KZ. Inpatient burden and outcomes across gastrointestinal cancer subtypes among younger adults in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11077
Tiwana E, Jones DT, Hearn E, Shawesh Q, Sheraz F, Thein KZ. Inpatient outcomes by socioeconomic characteristics among younger adults hospitalized with gastrointestinal malignancies in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23168
Hearn E, Shawesh Q, Jones DT, Tiwana E, Thein KZ, Sheraz F, Selleck M, Lenhart L. Trends in utilization and inpatient outcomes of minimally invasive colectomy for colorectal cancer in the United States, 2018–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23195
Hearn E, Sangha T, Manjikian A, Tiwana E, Latifi A, Tupas E, Ghobrial M, Shawesh Q, Hanspal A, Lenhart L, Jones DT, Selleck M, Thein KZ, Shah P. Inpatient Outcomes and Cost Utilization by Surgical Approach for Elective Non-Metastatic Colon Cancer Resection in the United States, 2018–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23189
Latifi A, Sheraz F, Manjikian A, Shawesh Q, Thein KZ, Jones DT, Liezel Lenhart, Matthew Selleck. Latifi A Inpatient outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the United States, 2018–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e15605
Tupas E, Latifi A, Ghobrial M, Jones DT, Thein KZ, Sheraz F. Admission Acuity and Inpatient Outcomes Across Major Gastrointestinal Malignancies in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11097
Ghobrial M, Sheraz F, Latifi A, Tupas EP, Jones DT, Thein KZ. Association of inpatient mortality and resource utilization with acute complications among colorectal cancer hospitalizations in the United States. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23220
Ghobrial M, Sheraz F, Latifi A, Tupas EP, Jones DT, Thein KZ. Inpatient outcomes and resource utilization by complication clustering phenotypes among colorectal cancer hospitalizations in the United States. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23215
Mathew J, Nichols C, Kheirollah S, Jones DT, Shetty K, Thein KZ. Aspiration pneumonitis and inpatient outcomes in adult cancer hospitalizations: A 2018–2022 National Inpatient Sample analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23217
Mathew J, Nichols C, Kheirollah S, Jones DT, Shetty K, Thein KZ. Infection-associated transitions to critical care–level interventions in adult cancer hospitalizations: A National Inpatient Sample analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23214
Nichols C, Jones DT, Mathew J, Kheirollah S, Shah P, Thein KZ. Mechanical ventilation timing categories and inpatient outcomes in adult cancer hospitalizations: A 2018–2022 National Inpatient Sample analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23095
Chaganlal P, Everett J, Jones DT, Thein KZ, Shah P. Cancer cachexia and wasting phenotypes in relation to inpatient severity, infection, resource utilization, and mortality in U.S. cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23199
Everett J, Chaganlal P, Jones DT, Thein KZ, Shah P. Diabetic ketoacidosis and hyperosmolar hyperglycemic state as high-acuity phenotypes in U.S. cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23197
Everett J, Chaganlal P, Jones DT, Thein KZ, Shah P. Electrolyte abnormalities and severity, mortality, and resource utilization in U.S. cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23190
Chaganlal P, Everett J, Jones DT, Thein KZ, Shah P. Endocrine stress phenotypes as drivers of extreme inpatient severity and resource utilization without increased mortality in cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23201
Tabbah T, Farrukh F, Jones DT, Thein KZ, Shah P. APS-TMA phenotypes as a failure-to-rescue signal during U.S. cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11041
Farrukh F, Tabbah T, Jones DT, Thein KZ, Shah P. Association of inpatient outcomes and resource utilization with an ICD-10–defined immune-related adverse event phenotype during U.S. cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e23104
Farrukh F, Tabbah T, Jones DT, Thein KZ, Shah P. Lineage-specific outcomes and resource utilization associated with antiphospholipid syndrome and thrombotic microangiopathy phenotypes during U.S. cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.e19110
American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) 2025 – Journal of Clinical Oncology (Impact Factor: 45.3)
Nanda RK, Aboaid H, Jones DT, Srinivasmurthy R, Nguyen K, Ta J, Thein KZ.. Meta-Analysis of Phase II/III Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Hand-Foot Skin Reaction (HFSR) or Palmar-Plantar Erythrodysesthesia (PPE) Syndrome in Patients with Gastrointestinal (GI) Cancers Treated with Fruquintinib. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). August 2024. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.4_suppl.117
Jones DT, Nanda RK, Aboaid H, Srinivasmurthy R, Nguyen K, Ta J, Thein KZ.. Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Hemorrhage and Venous Thromboembolism (VTE) Events in Patients with Gastrointestinal (GI) Cancers Treated with Fruquintinib. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). August 2024. Published. Article URL: https://doi.org/10.1200/JCO.2025.43.4_suppl.118
Srinivasmurthy R, Aboaid H, Jones DT, Nanda RK, Nguyen K, Ta J, Thein KZ.. Meta-Analysis of Phase II/III Randomized Controlled Trials (RCTs) to Determine the Incidence of Hypertension and Proteinuria in Patients with Gastrointestinal (GI) Cancers Treated with Fruquintinib. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). August 2024. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.4_suppl.119
American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) 2026 – Journal of Clinical Oncology (Impact Factor: 45.3)
Jones DT, Nanda RK, Larson CAJ, Thein KZ. The dual-obstruction phenotype in pancreatic cancer: National decompression patterns and inpatient burden, 2016–2023. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). January 2027. Publication Status: Accepted. Article URL:
Jones DT, Nanda RK, Larson CAJ, Thein KZ. Aspiration in esophageal cancer with dysphagia: A national high-risk phenotype with severe respiratory and inpatient burden. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). January 2027. Publication Status: Accepted. Article URL:
Jones DT, Nanda RK, Larson CAJ, Thein KZ. Concurrent venous thromboembolism and major bleeding in pancreatic cancer: National outcomes, 2016–2023. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). January 2027. Publication Status: Accepted. Article URL:
Jones DT, Nanda RK, Larson CAJ, Thein KZ. Venous thromboembolism despite thrombocytopenia in hepatocellular carcinoma with cirrhosis: A national analysis, 2016–2023. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). January 2027. Publication Status: Accepted. Article URL:
ASCO Quality Care Symposium 2026 – Journal of Clinical Oncology (Impact Factor: 45.3)
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. The Oncology Capability Gap: Failure-to-Rescue Following High-Risk Oncologic Emergencies in the United States. ASCO Quality Care Symposium. September 2026. Publication Status: Accepted. Article URL:
American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2027 – Journal of Clinical Oncology (Impact Factor: 44.7)
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Disseminated Intravascular Coagulation in Metastatic Prostate Cancer: A Predominantly Hemorrhagic National Phenotype With Sevenfold Higher Mortality. American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU). 2027. Publication Status: Submitted.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Concurrent Urinary Obstruction and Sepsis in Bladder Cancer: Renal Decompensation, Resource Burden, and National Patterns of Urinary Decompression. American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU). 2027. Publication Status: Submitted.
Larson CAJ, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Concurrent Hypercalcemia and Acute Kidney Injury in Renal Cell Carcinoma: A Rising High-Risk Metabolic-Renal Phenotype. American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU). 2027. Publication Status: Submitted.
Larson CAJ, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Penile and Urethral Cancer-Associated Fournier Gangrene: A National Analysis of Procedural Burden. American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU). 2027. Publication Status: Submitted.
European Society for Medical Oncology (ESMO) 2026 – Annals of Oncology (Impact Factor: 56.7)
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Comparative VEGF-Related and Hemorrhagic Toxicity of Ivonescimab-Based Therapy in Randomized Phase III NSCLC Trials. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Treatment Interruption and Discontinuation Patterns With KRAS G12C Inhibitors Versus Docetaxel in KRAS G12C-Mutated NSCLC. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Reduced Hematologic Toxicity With KRAS G12C Inhibitors Compared With Docetaxel in KRAS G12C-Mutated NSCLC: A Meta-analysis of Randomized Phase III Trials. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Comparative Hepatotoxicity of KRAS G12C Inhibitors Versus Docetaxel in Previously Treated KRAS G12C-Mutated NSCLC: A Meta-analysis of Randomized Phase III Trials. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Progression-Free Survival With Ivonescimab-Based Therapy in Advanced NSCLC Patients With Baseline Brain Metastases. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
National Comprehensive Cancer Network 2025 Annual Conference – Journal of the National Comprehensive Cancer Network (Impact Factor: 17.5)
Jones DT, Hussain A, Aboaid H, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Srinivasmurthy R, Thein KZ. HSR25-171: Risk of Health-Related Quality of Life (HRQOL) Events in Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab: A Meta-Analysis of Phase III Randomized Controlled Trials. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7315
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Ta J, Chuang BTM, Nanda RK, Myat YM, Thein KZ. HSR25-175: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Venous Thromboembolism (VTE) and Immune-Related Adverse Events (iRAEs) in Patients With Primary Advanced or Recurrent Endometrial Cancer Treated With Immunochemotherapy. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7341
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Ta J, Chuang BTM, Nanda RK, Myat YM, Thein KZ. HSR25-150: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Health-Related Quality of Life (HRQOL) Events in Patients with Primary Advanced or Recurrent Endometrial Cancer Treated With First-Line Immunochemotherapy. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7342
Ta J, Chuang BTM, Aboaid H, Jones DT, Srinivasmurthy R, Nguyen K, Nanda RK, Myat YM, Thein KZ. HSR25-198: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Hand-Foot Skin Reaction (HFSR) or Palmar-Plantar Erythrodysesthesia (PPE) in Patients With Cancers Treated With Fruquintinib. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7340
Srinivasmurthy R, Aboaid H, Hussain A, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Thein KZ. HSR25-152: Incidence of Hematologic Adverse Events in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab: A Meta-Analysis of Phase III Randomized Controlled Trials. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7316
Hattin R, Aboaid H, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ. HSR25-187: Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Gastrointestinal Adverse Events in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7317
Hattin R, Aboaid H, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ, Htut TW. HSR25-172: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Infectious Adverse Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7314
Srinivasmurthy R, Aboaid H, Jones DT, Nguyen K, Ta J, Chuang BTM, Nanda RK, Myat YM, Thein KZ. HSR25-176: Efficacy of Immunochemotherapy in Primary Advanced or Recurrent Endometrial Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials (RCTs). Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7330
Khalid T, Aboaid H, Jones DT, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Nanda RK, Aamer S, Bigcas JL, Thein KZ. HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7329
Hattin R, Hussain A, Aboaid H, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ, Htut TW. HSR25-143: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Systemic Toxicities in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7313
National Comprehensive Cancer Network 2027 Annual Conference – Journal of the National Comprehensive Cancer Network (Impact Factor: 17.5)
Larson CAJ, Win ZT, Hussain AA, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Chovatiya J, Lin WJ, Jones DT, Htwe K, Yang EH, Thein KZ. Cancer-Associated Takotsubo Syndrome as a High-Risk Critical Illness Phenotype: A National Inpatient Sample Analysis, 2016–2023. Accepted for presentation at the National Comprehensive Cancer Network 2027 Annual Conference. Accepted for publication in the Journal of the National Comprehensive Cancer Network. URL:
Larson CAJ, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Which Cancers Are Driving the Early-Onset Cancer Burden in the United States? Trends in Metastatic Presentation and Inpatient Mortality, 2016–2023. ASCO Quality Care Symposium. September 2026. Publication Status: Accepted. Article URL:
Larson CAJ, Nanda RK, Hsu J, Jones DT, Thein KZ. Greater Complication Burden but Comparable In-Hospital Mortality at Urban Teaching Hospitals in Acute Promyelocytic Leukemia: A National Analysis, 2016–2023. Accepted for presentation at the National Comprehensive Cancer Network 2027 Annual Conference. Accepted for publication in the Journal of the National Comprehensive Cancer Network. URL:
Larson CAJ, Nanda RK, Hsu J, Jones DT, Thein KZ. Sepsis Overrides ALK-Defined Prognostic Differences in Systemic Anaplastic Large Cell Lymphoma: A National Analysis, 2016–2023. Accepted for presentation at the National Comprehensive Cancer Network 2027 Annual Conference. Accepted for publication in the Journal of the National Comprehensive Cancer Network. URL:
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Pathologic Fracture in Primary Bone Malignancy: Limb Preservation, Perioperative Morbidity, and Resource Utilization in the United States. Accepted for presentation at the National Comprehensive Cancer Network 2027 Annual Conference. Accepted for publication in the Journal of the National Comprehensive Cancer Network. URL:
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Primary Pelvic and Sacral Bone Malignancies: National Patterns of Surgical Management and Inpatient Outcomes. Accepted for presentation at the National Comprehensive Cancer Network 2027 Annual Conference. Accepted for publication in the Journal of the National Comprehensive Cancer Network. URL:
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Concurrent Venous Thromboembolism and Major Bleeding Define a High-Risk Inpatient Phenotype in Bone and Soft Tissue Malignancy. Accepted for presentation at the National Comprehensive Cancer Network 2027 Annual Conference. Accepted for publication in the Journal of the National Comprehensive Cancer Network. URL:
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Age-Related Differences in Major Amputation and Inpatient Outcomes Among Adults With Primary Bone Malignancy. Accepted for presentation at the National Comprehensive Cancer Network 2027 Annual Conference. Accepted for publication in the Journal of the National Comprehensive Cancer Network. URL:
American Association for Cancer Research (AACR IO) 2025 – Cancer Immunology Research (Impact Factor: 8.1)
Nanda RK, Jones DT, Khalid T, Aboaid H, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials to Assess Risk of Locoregional Adverse Events in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B044
Jones DT, Nanda RK, Khalid T, Aboaid H, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Incidence of General Systemic Adverse Events in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B037
Srinivasmurthy R, Khalid T, Nanda RK, Jones DT, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Efficacy of the Addition of Immune Checkpoint Inhibitors in Patients with Locally Advanced Nasopharyngeal Carcinoma. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B039
Khalid T, Srinivasmurthy R, Nanda RK, Jones DT, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Assessing the risk of locoregional, general, hematological, and late adverse events in patients with locally advanced nasopharyngeal carcinoma treated with immune checkpoint inhibitors - a systematic review and meta-analysis. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B042
Srinivasmurthy R, Nanda RK, Jones DT, Khalid T, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Assess the Risk of Immune-Related Adverse Effects (irAEs) in Patients with Locally Advanced Nasopharyngeal Carcinoma Treated with Immune Checkpoint Inhibitors. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B043
San Antonio Breast Cancer Symposium (SABCS) 2026 – Clinical Cancer Research (Impact Factor: 10.9)
Larson CAJ, Lwin S, Efendi A, Hsu J, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. Pregnancy-Associated Breast Cancer Hospitalizations: Severe Maternal Morbidity, Critical Care Utilization, and Obstetric Outcomes in the United States, 2016–2023. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
Larson CAJ, Lwin S, Efendi A, Hsu J, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. Age-Specific Trends in Breast Cancer Hospitalizations, Metastatic Disease, and Inpatient Mortality in the United States, 2016–2023. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
Hsu J, Lwin S, Efendi A, Larson CAJ, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. The Influence of Race and Socioeconomic Status on Inpatient Palliative Care Integration During Terminal Admissions for Metastatic Breast Cancer in the United States, 2016–2022. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
Hsu J, Lwin S, Efendi A, Larson CAJ, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. Real-World Inpatient Footprint of Interstitial Lung Disease in Breast Cancer Hospitalizations. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
Lwin S, Efendi A, Larson CAJ, Hsu J, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. Acute Kidney Injury and Metabolic Emergencies in Breast Cancer Hospitalizations: Prevalence, Dialysis Utilization, and Mortality Risk, 2016–2023. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
Lwin S, Efendi A, Larson CAJ, Hsu J, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. Anatomic Tumor Location and Metastatic Disease Burden Among Breast Cancer Hospitalizations in the United States: A National Inpatient Sample Analysis, 2016–2023. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
Efendi A, Lwin S, Larson CAJ, Hsu J, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. Sex-Based Differences in Complication Burden Among Adults Hospitalized With Breast Cancer, 2016–2023. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
Efendi A, Lwin S, Larson CAJ, Hsu J, Nanda RK, Sajid S, Myat YM, Jones DT, Ho L, Thein KZ. Delirium as a Marker of Inpatient Deterioration Among Older Women Hospitalized With Breast Cancer, 2016–2023. San Antonio Breast Cancer Symposium (SABCS). July 2026. Publication Status: Submitted. Article URL:
American Society for Radiation Oncology (ASTRO) 2025 – International Journal of Radiation Oncology • Biology • Physics (Impact Factor: 6.4)
Tun T, Khalid T, Aboaid H, Jones DT, Nanda RK, Win ZT, Afifi S, Srinivasmurthy R, Ta J, Bigcas JL, Thein KZ. Efficacy and Safety of Immunotherapy Versus Cetuximab Concurrent with Radiotherapy in Cisplatin-Ineligible Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. American Society of Radiation Oncology (ASTRO) 2025. September 28, 2025. Publication Status: Published. Article URL: https://doi.org/10.1016/j.ijrobp.2025.06.2382
Society of Hematologic Oncology (SOHO) 2025 – Clinical Lymphoma, Myeloma & Leukemia (Impact Factor: 2.7)
Mkrtchyan N, Dermarderosian A, Jones DT, Nanda RK, Yeremian S, Evangelista E, Carbajal E, Siringoringo D, Park D, Akhtari M. Exploring Side Effect Profile of Bruton Tyrosine Kinase Inhibitors on the Cardiovascular System. Society of Hematologic Oncology (SOHO) 2025. September 4, 2025. Publication Status: Published. Article URL: https://doi.org/10.1016/S2152-2650(25)01891-9
Society of Hematologic Oncology (SOHO) 2026 – Clinical Lymphoma, Myeloma & Leukemia (Impact Factor: 2.7)
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Escalation-of-Care Phenotypes and Progressive Inpatient Deterioration in Acute Myeloid Leukemia: A National Inpatient Sample Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: https://doi.org/10.1016/S2152-2650(26)01928-2
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Failure-to-Rescue and Critical Illness Phenotypes in Acute Myeloid Leukemia Hospitalizations With Sepsis: A National Inpatient Sample Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: https://doi.org/10.1016/S2152-2650(26)01925-7
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Hospital Acute Myeloid Leukemia Volume and Inpatient Mortality Among Acute Myeloid Leukemia Hospitalizations With Sepsis: A National Inpatient Sample Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: https://doi.org/10.1016/S2152-2650(26)01927-0
Nanda RK, Jones DT, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: https://doi.org/10.1016/S2152-2650(26)02099-9
Nanda RK, Jones DT, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: https://doi.org/10.1016/S2152-2650(26)02097-5
Nanda RK, Jones DT, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Pirtobrutinib Following Covalent BTK Inhibitor Exposure in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Pooled Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: https://doi.org/10.1016/S2152-2650(26)02089-6
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2025 – Molecular Cancer Therapeutics (Impact Factor: 5.4)
Jones DT, Hattin R, Ta J, Hussain A, Srinivasmurthy R, Nanda RK, Lam C, Thein KZ. Efficacy of amivantamab in patients with EGFR-mutated non-small cell lung cancer (NSCLC): A systematic review and combined meta-analysis of phase 3 randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-B063
Jones DT, Srinivasmurthy R, Ta J, Nanda RK, Hussain A, Hattin R, Thein KZ. Tolerability and ocular adverse events of datopotamab deruxtecan in advanced cancers: A systematic review and meta-analysis of phase III trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A095
Srinivasmurthy R, Ta J, Jones DT, Hussain A, Hattin R, Nanda RK, Thein KZ. Incidence of gastrointestinal adverse events in advanced or metastatic cancer patients treated with datopotamab deruxtecan: A systematic review and meta-analysis of phase III randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-C055
Srinivasmurthy R, Nanda RK, Jones DT, Khalid T, Ta J, Do K, Hattin R, Hussain A, Myat YM, Bigcas JL, Thein KZ. Risk of immune-related adverse events with immune checkpoint inhibitors in locally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis of randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-C056
Ta J, Nanda RK, Jones DT, Srinivasmurthy R, Hussain A, Hattin R, Lam C, Thein KZ. Incidence of pulmonary and hematologic adverse events in advanced or metastatic cancer patients treated with datopotamab deruxtecan: A systematic review and meta-analysis of phase III randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A141
Ta J, Hussain A, Hattin R, Jones DT, Srinivasmurthy R, Nanda RK, Lam C, Thein KZ. Risk of dermatologic adverse events with amivantamab in EGFR-mutant non–small cell lung cancer: A systematic review and meta-analysis of phase III trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A142
Ta J, Srinivasmurthy R, Jones DT, Khalid T, Hattin R, Hussain A, Do K, Nanda RK, Myat YM, Bigcas JL, Thein KZ. Toxicity profile of immune checkpoint inhibitors in locoregionally advanced nasopharyngeal carcinoma: A meta-analysis of general and hematologic adverse events from phase II and III randomized trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A143
Srinivasmurthy R, Ta J, Jones DT, Hattin R, Nanda R, Khalid T, Hussain A, Do K, Bigcas JL, Thein KZ. Locoregional toxicities associated with immunotherapy plus chemoradiation in locally advanced head and neck cancer: A systematic review and meta-analysis of phase 3 trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-C057
American Heart Association (AHA) 2025 – Circulation Journal (Impact Factor: 37.8)
Win ZT, Hussain AA, Srinivasmurthy R, Hattin R, Nanda RK, Jones DT, Chu MJ, Ta J, Tun T, Aboaid H, Nguyen KK, Myat YM, Mohib K, Macias A, Htwe KK, Thein KZ. Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to Control. American Heart Association (AHA). November 2025. Publication Status: Accepted for Publication. Article URL: https://doi.org/10.1161/circ.152.suppl_3.4367292
American Heart Association (AHA) 2026 – Circulation Journal (Impact Factor: 37.8)
Win ZT, Larson CAJ, Hussain AA, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Chovatiya J, Lin WJ, Jones DT, Htwe KK, Yang EH, Thein KZ. Distinct Inpatient Phenotypes of Transthyretin and Light-Chain Amyloidosis Hospitalizations in the United States: A National Inpatient Sample Analysis, 2017–2023. American Heart Association (AHA). November 2026. Publication Status: Accepted for Publication.
Win ZT, Srinivasmurthy R, Nanda RK, Ta J, Hattin R, Hussain AA, Larson CAJ, Chovatiya J, Lin WJ, Jones DT, Thein KZ, Yang EH. Acute Cardiovascular Decompensation in Renal Cell Carcinoma Hospitalizations: National Inpatient Outcomes and Failure-to-Rescue (NIS 2016–2023). American Heart Association (AHA). November 2026. Publication Status: Accepted for Publication.
American College of Cardiology Annual Scientific Session 2027 / Journal of the American College of Cardiology (Impact Factor: 22.3)
Kapadia S, Srinivasmurthy R, Jones DT. “The Cardiorenal Burden of Lupus Nephritis in Patients Hospitalized With SLE-Associated Pericarditis: A National Inpatient Analysis.” American College of Cardiology Annual Scientific Session 2026. Accepted for presentation. Published in Journal of the American College of Cardiology conference supplement. URL:
Chattha S, Jones DT. “Cardiovascular-Kidney-Metabolic Multimorbidity in Acute Diastolic Heart Failure: National Outcomes and Resource Burden.” American College of Cardiology Annual Scientific Session. 2027.
Chattha S, Jones DT. “Who Reaches Advanced Cardiogenic Shock Centers? National Disparities in Transfer Destination and Outcomes, 2016-2023.” American College of Cardiology Annual Scientific Session. 2027.
Hassan M, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “The Obesity-Malnutrition Phenotype in Heart Failure With Preserved Ejection Fraction: National Outcomes and Resource Utilization.” American College of Cardiology Annual Scientific Session. 2027.
Hashmi M, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Malignancy and Temporary Mechanical Circulatory Support in Cardiogenic Shock: National Utilization and Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Khachatryan M, Alkhayat M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Polyvascular Ischemic Catastrophe: Concurrent Limb and Mesenteric Ischemia and National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Rubinstein M, Alkhayat M, Khachatryan M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “The Gut-Shock Phenotype: Acute Mesenteric Ischemia in Cardiogenic Shock and National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Seifert G, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “The Right-Heart-Kidney Double Hit in Pulmonary Arterial Hypertension: National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Nicolaou A, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Pulmonary Hypertension and Severe Preeclampsia/Eclampsia: National Maternal Cardiovascular Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Hassan M, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Brain-Kidney Vulnerability in Geriatric Acute Heart Failure: National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Seifert G, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Renal Dominance in Right-Sided Multiorgan Decompensation With Tricuspid Regurgitation.” American College of Cardiology Annual Scientific Session. 2027.
Rubinstein M, Alkhayat M, Khachatryan M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Divergent Arterial Phenotypes in Cancer-Associated Disseminated Intravascular Coagulation: Myocardial Infarction, Ischemic Stroke, and National Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Concurrent Acute Myocardial Infarction and Ischemic Stroke in Cancer: A High-Risk Arterial Thrombotic Phenotype.” American College of Cardiology Annual Scientific Session. 2027.
Hassan M, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “AL Versus Wild-Type ATTR Cardiac Amyloidosis: National Trends, Outcomes, and Resource Utilization.” American College of Cardiology Annual Scientific Session. 2027.
Krason B, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Mesenteric Ischemia in Temporary Mechanical Circulatory Support-Supported Cardiogenic Shock: National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Hashmi M, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Pregnancy-Associated Coronary Dissection and Severe Hypertensive Disorders of Pregnancy: National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Nicolaou A, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Rising Stimulant-Related Disorders in Premature Myocardial Infarction: National Trends and Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Krason B, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Eisenmenger Syndrome, Atrial Arrhythmia, and Acute Right-Heart Failure: National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Butros S, Alkhayat M, Khachatryan M, Rubinstein M, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Multi-Territory Ischemic Injury in Aortic Dissection: Systemic Ischemic Burden and National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Butros S, Alkhayat M, Khachatryan M, Rubinstein M, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “The Thrombohemorrhagic Paradox in Atrial Fibrillation: Concurrent Ischemic Stroke and Gastrointestinal Bleeding.” American College of Cardiology Annual Scientific Session. 2027.
Khachatryan M, Alkhayat M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Neurologic Catastrophe in Prosthetic Valve Endocarditis: Ischemic Stroke, Intracranial Hemorrhage, and National Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Seifert G, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Multi-Territory Ischemic Injury in Infective Endocarditis: Systemic Ischemic Burden and National Inpatient Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Seifert G, Alkhayat M, Khachatryan M, Rubinstein M, Butros S, Nicolaou A, Hassan M, Hashmi M, Krason B, Macias A, Win ZT, Chattha S, Jones DT, Thein KZ. “Electrical-Hemodynamic Collapse in Acute Myocarditis: Ventricular Arrhythmia, Cardiogenic Shock, and National Outcomes.” American College of Cardiology Annual Scientific Session. 2027.
Marcias A, Hassan M, Seifert G, Alkhayat M, Khachatryan M, Rubinstein M, Chattha S, Nicolaou A, Hashmi M, Butros S, Krason B, Jones DT, Thein KZ. “Rapid National Adoption of Leadless Pacing During Tricuspid Valve Surgery Hospitalizations.” American College of Cardiology Annual Scientific Session. 2027.
Marcias A, Hassan M, Seifert G, Alkhayat M, Khachatryan M, Rubinstein M, Chattha S, Nicolaou A, Hashmi M, Butros S, Krason B, Jones DT, Thein KZ. “National Decline and Procedural Shift in Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy, 2016-2023.” American College of Cardiology Annual Scientific Session. 2027.
American Society for Radiation Oncology (ASTRO) – Multidisciplinary Head & Neck Cancers Symposium 2026 – International Journal of Radiation Oncology • Biology • Physics (Impact Factor: 8.1)
Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Myat YM, Hussain A, Hattin R, Khalid T, Tian S, Shah S, Francis S, Bigcas J, Thein KZ. Differential Efficacy of PD-1 and PD-L1 Inhibitors in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials. American Society for Radiation Oncology (ASTRO) – Multidisciplinary Head & Neck Cancers Symposium. February 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the International Journal of Radiation Oncology • Biology • Physics (Red Journal). Article URL: https://doi.org/10.1016/j.ijrobp.2026.02.097
Hussain A, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Myat YM, Hattin R, Khalid T, Tian S, Shah S, Francis S, Bigcas J, Thein KZ. Definitive vs Peri-Operative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials. American Society for Radiation Oncology (ASTRO) – Multidisciplinary Head & Neck Cancers Symposium. February 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the International Journal of Radiation Oncology • Biology • Physics (Red Journal). Article URL:
American College of Gastroenterology (ACG) Annual Scientific Meeting 2026 – American Journal of Gastroenterology (Impact Factor: 10.8)
Sheraz F, Jones DT. Racial, Insurance-Based, and Socioeconomic Disparities in Acute Pancreatitis Outcomes: A Contemporary National Inpatient Sample Analysis, 2016–2023. American College of Gastroenterology (ACG) Annual Scientific Meeting. 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the American Journal of Gastroenterology (AJG). Article URL:
Sheraz F, Jones DT. Trends in MASLD-Related Cirrhosis Hospitalizations and Impact of Metabolic Comorbidity Burden on Inpatient Outcomes in the United States, 2016–2023. American College of Gastroenterology (ACG) Annual Scientific Meeting. 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the American Journal of Gastroenterology (AJG). Article URL:
Sheraz F, Jones DT. Gender Disparities in Inflammatory Bowel Disease Hospitalizations: Outcomes, Complications, and Healthcare Utilization in the United States, 2018–2023. American College of Gastroenterology (ACG) Annual Scientific Meeting. 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the American Journal of Gastroenterology (AJG). Article URL:
American Diabetes Association (ADA) Scientific Sessions 2026 – Diabetes (Impact Factor: 8.4)
Everett J, Chaganal P, Jones DT, Shah P. Diabetes as a Disease-Specific Modifier of Inpatient Outcomes across High-Acuity Medical Admissions: An Analysis of the 2016–2023 National Inpatient Sample. American Diabetes Association (ADA) Scientific Sessions. June 2026. Publication Status: Published. Article URL: https://doi.org/10.2337/db26-2275-P
.
Everett J, Chaganal P, Jones DT, Shah P. Reexamining the Diabetes Paradox: A National Analysis of Hyperglycemia across Acute Cardiovascular and Pulmonary Hospitalizations, 2016–2023. American Diabetes Association (ADA) Scientific Sessions. June 2026. Publication Status: Published. Article URL: https://doi.org/10.2337/db26-2276-P
Endocrine Society (ENDO) Annual Meeting 2027 – Journal of the Endocrine Society (Impact Factor: 3.5)
Chaganlal P, Everett J, Jones DT, Thein KZ, Shah P. Adrenal Insufficiency in Shock-Free Cancer Hospitalizations and Its Association With Extreme Inpatient Severity and Mechanical Ventilation: National Inpatient Sample, 2018–2022. Endocrine Society (ENDO) Annual Meeting. June 2027. Publication Status: Accepted. Article URL:
North American Spine Society 2026 Annual Meeting – The Spine Journal (Impact Factor: 5.1)
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Concurrent Obesity and Malnutrition in Degenerative Lumbar Fusion: National Outcomes, Post-Acute Care Needs, and Resource Utilization. Accepted for presentation at the North American Spine Society 2026 Annual Meeting. Accepted for publication in The Spine Journal. URL:
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Failure-to-Rescue After Degenerative Cervical Myelopathy Surgery: Complication Burden and Malnutrition Identify High-Risk National Phenotypes. Accepted for presentation at the North American Spine Society 2026 Annual Meeting. Accepted for publication in The Spine Journal. URL:
American Orthopaedic Society for Sports Medicine 2027 Annual Meeting - Orthopaedic Journal of Sports Medicine (Impact Factor: 2.5)
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Limb-Threatening Vascular Injury After Acute Knee Dislocation: National Patterns of Compartment Syndrome, Revascularization, and Limb Loss. Accepted for presentation at the American Orthopaedic Society for Sports Medicine 2027 Annual Meeting. Accepted for publication in the Orthopaedic Journal of Sports Medicine. URL:
Ward M, Nanda RK, Larson CAJ, Jones DT, Thein KZ. Renal Dysfunction Predicts Post-Acute Care Needs and Resource Utilization After Surgically Managed Acute Knee Extensor Mechanism Injury. Accepted for presentation at the American Orthopaedic Society for Sports Medicine 2027 Annual Meeting. Accepted for publication in the Orthopaedic Journal of Sports Medicine. URL:
American College of Rheumatology Convergence 2026
Farrukh F, Tabbah T, Jones DT, Choi J, Farrukh DN, Shah P. Inpatient Outcomes of Acute Venous Thromboembolism in Systemic Lupus Erythematosus and Vasculitis: A National Inpatient Sample Retrospective Cohort Study. American College of Rheumatology (ACR) Convergence. 2026. Publication Status: Accepted, Poster Presentation. Submission ID: 2454860. URL:
Farrukh F, Tabbah T, Jones DT, Thein KZ, Shah P. National Burden, Outcomes, and Resource Utilization Associated With Antiphospholipid Syndrome and Thrombotic Microangiopathy Phenotypes During Cancer Hospitalizations: A National Inpatient Sample Analysis, 2018–2022. American College of Rheumatology (ACR) Convergence. 2026. Publication Status: Accepted, Poster Presentation. Submission ID: 2431595. URL:
Tabbah T, Farrukh F, Jones DT, Choi J, Farrukh DN, Shah P. Paradoxical Cardioprotection in RA and PsA: Demonstration of Berkson’s Bias Via National Inpatient Sample, 2016–2023. American College of Rheumatology (ACR) Convergence. 2026. Publication Status: Accepted, Poster Presentation. Submission ID: 2450518. URL:
Tabbah T, Farrukh F, Jones DT, Choi J, Farrukh DN, Shah P. Racial and Social Disparities in Inpatient Outcomes Among Adults with SLE: A Nationwide Analysis, 2016–2023. American College of Rheumatology (ACR) Convergence. 2026. Publication Status: Accepted, Poster Presentation. Submission ID: 2431079. URL:
Digestive Disease Week 2027 - Gastroenterology (Impact Factor: 29.7)
Mehdi, Jones DT. The Thrombosis–Bleeding Paradox in Hospitalized Ulcerative Colitis: National Outcomes of Concurrent Venous Thromboembolism and Major Gastrointestinal Bleeding, 2016–2023. Digestive Disease Week 2027.
Mehdi, Jones DT. Cumulative Atopic Disease Burden and Irritable Bowel Syndrome in U.S. Hospitalizations: A National Dose–Response Analysis, 2016–2023. Digestive Disease Week 2027.
Case Reports (6)
PubMed-
Jones DT, Cruz G, Lugue MT, Heer MS, Sai M, Pace C, Bui L, Silver SA.. Fruquintinib-Induced Cerebellar Hemorrhage in Left-Sided Descending Metastatic Colorectal Adenocarcinoma: A Case Report and Risk Assessment. Cureus. August 2024; 16(8):e68203. Cited in PubMed; PMID: 39221315. Publication Status: Published. Article URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11364494/
Jones DT, Srinivasmurthy R, Pandit M, Tovar R, Ho L, Wairimu K.. Raoultella ornithinolytica Urinary Tract Infection in a Patient With Triple-Negative Breast Cancer. Cureus. July 2024; 16(7):e64742. Cited in PubMed; PMID: 39021744. Publication Status: Published. Article URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254315/
Chaganlal PP, Kalandoor V, Jones DT, Pace C, Silver SA.. Advanced Calciphylaxis in a Patient With End-Stage Renal Disease: A Case Report Highlighting Diagnostic and Therapeutic Challenges in Late-Stage Presentation. Cureus. September 2024; 16(9):e68866. Cited in PubMed; PMID: 39246637. Publication Status: Published. Article URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380459/
Cruz G, Jones DT, Lugue MT, Heer M, Pace C, Bui L, Silver SA.. Calyceal Rupture Secondary to Nephrolithiasis: A Case Report Emphasizing Early Diagnosis and Management. Cureus. August 2024; 16(8):e68305. Cited in PubMed; PMID: 39221315. Publication Status: Published. Article URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11365524/
Lugue MT, Cruz G, Jones DT, Heer MS, Bui L, Pace C, Silver SA.. Severe Pneumatosis Intestinalis and Hepatic Portal Venous Gas in a Patient With Methamphetamine Use: Early Recognition and Management. Cureus. August 2024; 16(8):e68017. Cited in PubMed; PMID: 39211828. Publication Status: Published. Article URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361326/
Tovar R, Jones DT, Srinivasmurthy R, Pandit M, Ho L. Pregabalin-Induced Bullous Pemphigoid: A Case Report of Rare Drug-Triggered Autoimmune Skin Disorder. Cureus. September 2024; 16(9):e69649. Cited in PubMed; PMID: 39296925. Publication Status: Published. Article URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11409904/
Oral Presentations (2)
International Academy of Cardiovascular Sciences (IACS-NAS) – Canadian Journal of Physiology and Pharmacology (Impact Factor: 2.273)
Nanda RK, Jones DT, Win ZT, Hussain AA, Hattin R, Srinivasmurthy R, Ta J, Chu T, Tun T, Aboaid H, Myat YM, Nguyen KK, Macias A, Thein KZ, Htwe KK, Htut TW. Bleeding Risk with Next-Generation BTK Inhibitors: A Meta-Analysis of Randomized Controlled Trials. International Academy of Cardiovascular Sciences (IACS-NAS). 2025. Publication Status: Published.
Congress of Clinical Rheumatology (CCR) West 2025 – North American Young Rheumatology Investigator Forum (NYRIF)
Farrukh F, Tabbah T, Jones DT, Choi J, Shah P. Inpatient Outcomes of Acute Venous Thromboembolism in Systemic Lupus Erythematosus and Vasculitis: A National Inpatient Sample Retrospective Cohort Study. Congress of Clinical Rheumatology (CCR) West 2025 - North American Young Rheumatology Investigator Forum (NYRIF). 2025. Presentation Type: Poster. Publication Status: Accepted.
Poster Presentations (143)
American Society of Hematology (ASH) 2024-
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Nanda RK, Thein KZ, Htut TW.. Updated Meta-Analysis of Phase III Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Pneumonia, Upper Respiratory Tract Infections (URTIs) and Venous Thromboembolism (VTE) in Patients with Multiple Myeloma Treated with Isatuximab. American Society of Hematology (ASH). July 2024. Publication Status: Published. Article URL: https://doi.org/10.1182/blood-2024-211295
American Society of Hematology (ASH) 2025 -
Hussain A, Jones DT, Ta J, Srinivasmurthy R, Nanda RK, Hattin R, Winland L, Karamian P, Joseph Y, Mohib K, Win ZT, Tun T, Dhillon M, Thein KZ, Htut TW. Incidence of Cardiac Toxicities in Patients with Hematologic Malignancies Treated with Zanubrutinib Compared to Control, including BTK Inhibitor (Ibrutinib): A Meta-Analysis of Randomized Controlled Trials. American Society of Hematology (ASH). December 2025. Publication Status: Pending Publication. Article URL:
Ta J, Hussain A, Jones DT, Srinivasmurthy R, Nanda RK, Hattin R, Khalid A, Ahmad S, Afifi S, Win ZT, Tun T, Dhillon M, Thein KZ, Htut TW. Incidence of Bleeding and Hypertension in Patients with Hematologic Malignancies Treated with Next-Generation Bruton Tyrosine Kinase (BTK) Inhibitors: A Meta-Analysis of Randomized Controlled Trials. American Society of Hematology (ASH). December 2025. Publication Status: Pending Publication. Article URL:
Nanda RK, Jones DT, Srinivasmurthy R, Ta J, Hussain A, Hattin R, Winland L, Karamian P, Joseph Y, Mohib K, Myat YM, Tun T, Dhillon M, Thein KZ, Htut TW. Incidence of Second Primary Malignancies in Patients with Hematologic Malignancies Treated with Next-Generation Bruton Tyrosine Kinase (BTK) Inhibitors: A Meta-Analysis of Randomized Controlled Trials. American Society of Hematology (ASH). December 2025. Publication Status: Pending Publication. Article URL:
American Society of Clinical Oncology (ASCO) 2025-
Aboaid H, Khalid T, Jones DT, Nanda RK, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Efficacy of definitive radiotherapy with concurrent and adjuvant immune checkpoint inhibitors in patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). May 2025. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.6062
Aboaid H, Hussain A, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ. Incidence of venous thromboembolism (VTE) events in patients with EGFR-mutant non-small cell lung cancer (NSCLC) treated with Amivantamab: A systematic review and combined meta-analysis of phase 3 randomized controlled trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). May 2025. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.12042
Hattin R, Aboaid H, Jones DT, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Srinivasmurthy R, Thein KZ, Htut TW. Incidence of ocular toxicities in patients with relapsed/refractory multiple myeloma treated with Belantamab Mafodotin: A systematic review and meta-analysis of phase 3 randomized controlled trials. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO). May 2025. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.12040
American Society of Clinical Oncology (ASCO) 2026-
Dhillon M, Hanspal A, Vu T, Jones DT, Thein KZ, Rahman F. Dysphagia-associated inpatient risk phenotypes and mortality in hospitalized head and neck cancer: A national analysis. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11085
Upreti S, Makhdoom E, Hanspal A, Jones DT, Sheraz F, Thein KZ, Vu T. Racial and payer-based disparities in inpatient resource utilization and mortality among patients hospitalized with head and neck cancer in the United States, 2018 to 2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11099
Tupas E, Latifi A, Ghobrial M, Jones DT, Thein KZ, Sheraz F. Admission Acuity and Inpatient Outcomes Across Major Gastrointestinal Malignancies in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11097
Tabbah T, Farrukh F, Jones DT, Thein KZ, Shah P. APS-TMA phenotypes as a failure-to-rescue signal during U.S. cancer hospitalizations: National Inpatient Sample, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11041
Tiwana E, Jones DT, Hearn E, Shawesh Q, Sheraz F, Thein KZ. Inpatient burden and outcomes across gastrointestinal cancer subtypes among younger adults in the United States, 2018–2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11077
Lee D, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Hussain A, Larson CAJ, Jones DT, Thein KZ. Heart failure in hospitalizations for hematologic malignancies versus solid tumors: National burden and inpatient outcomes, 2018-2022. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11074
Lin WJ, Srinivasmurthy R, Nanda RK, Ta J, Hattin R, Hussain A, Larson CAJ, Jones DT, Thein KZ. Hidden advanced physiology in non-metastatic gastrointestinal cancer: Malnutrition/cachexia and in-patient failure-to-rescue. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11102
Larson CAJ, Srinivasmurthy R, Nanda RK, Ta J, Jones DT, Thein KZ. Malnutrition and cachexia as drivers of failure-to-rescue in gynecologic cancer hospitalizations, 2016–2023. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11053
Peterson S, Nanda RK, Larson CAJ, Ta J, Srinivasmurthy R, Thein KZ, Jones DT. Shifting drivers of hospitalization in endometrial cancer: Toxicity-like organ failure phenotypes in the modern treatment era. American Society of Clinical Oncology (ASCO) Annual Meeting. 2026. Publication Status: Accepted. Article URL: https://www.doi.org/10.1200/JCO.2026.44.16_suppl.11066
American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) 2025-
Nanda RK, Aboaid H, Jones DT, Srinivasmurthy R, Nguyen K, Ta J, Thein KZ.. Meta-Analysis of Phase II/III Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Hand-Foot Skin Reaction (HFSR) or Palmar-Plantar Erythrodysesthesia (PPE) Syndrome in Patients with Gastrointestinal (GI) Cancers Treated with Fruquintinib. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). August 2024. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.4_suppl.117
Jones DT, Nanda RK, Aboaid H, Srinivasmurthy R, Nguyen K, Ta J, Thein KZ.. Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Hemorrhage and Venous Thromboembolism (VTE) Events in Patients with Gastrointestinal (GI) Cancers Treated with Fruquintinib. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). August 2024. Published. Article URL: https://doi.org/10.1200/JCO.2025.43.4_suppl.118
Srinivasmurthy R, Aboaid H, Jones DT, Nanda RK, Nguyen K, Ta J, Thein KZ.. Meta-Analysis of Phase II/III Randomized Controlled Trials (RCTs) to Determine the Incidence of Hypertension and Proteinuria in Patients with Gastrointestinal (GI) Cancers Treated with Fruquintinib. American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI). August 2024. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.4_suppl.119
ASCO Quality Care Symposium 2026 – Journal of Clinical Oncology (Impact Factor: 45.3)
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. The Oncology Capability Gap: Failure-to-Rescue Following High-Risk Oncologic Emergencies in the United States. ASCO Quality Care Symposium. September 2026. Publication Status: Accepted. Article URL:
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Thein KZ. Which Cancers Are Driving the Early-Onset Cancer Burden in the United States? Trends in Metastatic Presentation and Inpatient Mortality, 2016–2023. ASCO Quality Care Symposium. September 2026. Publication Status: Accepted. Article URL:
European Society for Medical Oncology (ESMO) 2026 – Annals of Oncology (Impact Factor: 56.7)
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Comparative VEGF-Related and Hemorrhagic Toxicity of Ivonescimab-Based Therapy in Randomized Phase III NSCLC Trials. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Treatment Interruption and Discontinuation Patterns With KRAS G12C Inhibitors Versus Docetaxel in KRAS G12C-Mutated NSCLC. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Reduced Hematologic Toxicity With KRAS G12C Inhibitors Compared With Docetaxel in KRAS G12C-Mutated NSCLC: A Meta-analysis of Randomized Phase III Trials. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Comparative Hepatotoxicity of KRAS G12C Inhibitors Versus Docetaxel in Previously Treated KRAS G12C-Mutated NSCLC: A Meta-analysis of Randomized Phase III Trials. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Shanshal M, Thein KZ. Progression-Free Survival With Ivonescimab-Based Therapy in Advanced NSCLC Patients With Baseline Brain Metastases. European Society for Medical Oncology (ESMO) Congress 2026. Publication Status: Accepted for Presentation. Article URL: Pending.
National Comprehensive Cancer Network (NCCN) 2025-
Jones DT, Hussain A, Aboaid H, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Srinivasmurthy R, Thein KZ. HSR25-171: Risk of Health-Related Quality of Life (HRQOL) Events in Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab: A Meta-Analysis of Phase III Randomized Controlled Trials. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7315
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Ta J, Chuang BTM, Nanda RK, Myat YM, Thein KZ. HSR25-175: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Venous Thromboembolism (VTE) and Immune-Related Adverse Events (iRAEs) in Patients With Primary Advanced or Recurrent Endometrial Cancer Treated With Immunochemotherapy. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7341
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Ta J, Chuang BTM, Nanda RK, Myat YM, Thein KZ. HSR25-150: Meta-Analysis of Randomized Controlled Trials (RCTs) to Evaluate the Incidence of Health-Related Quality of Life (HRQOL) Events in Patients with Primary Advanced or Recurrent Endometrial Cancer Treated With First-Line Immunochemotherapy. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7342
Ta J, Chuang BTM, Aboaid H, Jones DT, Srinivasmurthy R, Nguyen K, Nanda RK, Myat YM, Thein KZ. HSR25-198: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Hand-Foot Skin Reaction (HFSR) or Palmar-Plantar Erythrodysesthesia (PPE) in Patients With Cancers Treated With Fruquintinib. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7340
Srinivasmurthy R, Aboaid H, Hussain A, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Thein KZ. HSR25-152: Incidence of Hematologic Adverse Events in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab: A Meta-Analysis of Phase III Randomized Controlled Trials. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7316
Hattin R, Aboaid H, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ. HSR25-187: Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Gastrointestinal Adverse Events in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7317
Hattin R, Aboaid H, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ, Htut TW. HSR25-172: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Infectious Adverse Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7314
Srinivasmurthy R, Aboaid H, Jones DT, Nguyen K, Ta J, Chuang BTM, Nanda RK, Myat YM, Thein KZ. HSR25-176: Efficacy of Immunochemotherapy in Primary Advanced or Recurrent Endometrial Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials (RCTs). Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7330
Khalid T, Aboaid H, Jones DT, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Nanda RK, Aamer S, Bigcas JL, Thein KZ. HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7329
Hattin R, Hussain A, Aboaid H, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, Thein KZ, Htut TW. HSR25-143: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Systemic Toxicities in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin. Journal of the National Comprehensive Cancer Network (JNCCN). March 2025. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7313
American Association for Cancer Research (AACR IO) 2025-
Nanda RK, Jones DT, Khalid T, Aboaid H, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials to Assess Risk of Locoregional Adverse Events in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B044
Jones DT, Nanda RK, Khalid T, Aboaid H, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Incidence of General Systemic Adverse Events in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B037
Srinivasmurthy R, Khalid T, Nanda RK, Jones DT, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Efficacy of the Addition of Immune Checkpoint Inhibitors in Patients with Locally Advanced Nasopharyngeal Carcinoma. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B039
Khalid T, Srinivasmurthy R, Nanda RK, Jones DT, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Assessing the risk of locoregional, general, hematological, and late adverse events in patients with locally advanced nasopharyngeal carcinoma treated with immune checkpoint inhibitors - a systematic review and meta-analysis. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B042
Srinivasmurthy R, Nanda RK, Jones DT, Khalid T, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Assess the Risk of Immune-Related Adverse Effects (irAEs) in Patients with Locally Advanced Nasopharyngeal Carcinoma Treated with Immune Checkpoint Inhibitors. American Association for Cancer Research (AACR IO). February 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/2326-6074.IO2025-B043
American Society of Clinical Oncology (ASCO) Student/Resident 2025-
Khalid T, Aboaid H, Hussain A, Jones DT, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Nanda R, Aamer S, Bigcas JL, Thein KZ. Incidence of Locoregional Adverse Events from the Addition of Immunotherapy to Standard-of-Care Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. Poster Presentation. ASCO 2025, May 31, 2025.
American Society for Radiation Oncology (ASTRO) 2025 – International Journal of Radiation Oncology • Biology • Physics (Impact Factor: 6.4)
Tun T, Khalid T, Aboaid H, Jones DT, Nanda RK, Win ZT, Afifi S, Srinivasmurthy R, Ta J, Bigcas JL, Thein KZ. Efficacy and Safety of Immunotherapy Versus Cetuximab Concurrent with Radiotherapy in Cisplatin-Ineligible Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. American Society of Radiation Oncology (ASTRO) 2025. September 28, 2025. Publication Status: Published. Article URL: https://doi.org/10.1016/j.ijrobp.2025.06.2382
American Head and Neck Society (AHNS) 2025 – JAMA Otolaryngology–Head & Neck Surgery (Impact Factor: 6.1)
Khalid T, Aboaid H, Jones DT, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Nanda R, Bigcas JL, Thein KZ. Addition of Immunotherapy to Standard-of-Care Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta-Analysis. American Head and Neck Society (AHNS). December 2024. Publication Status: Pending Publication.
Society of Hematologic Oncology (SOHO) 2025 – Clinical Lymphoma, Myeloma & Leukemia (Impact Factor: 2.7)
Mkrtchyan N, Dermarderosian A, Jones DT, Nanda RK, Yeremian S, Evangelista E, Carbajal E, Siringoringo D, Park D, Akhtari M. Exploring Side Effect Profile of Bruton Tyrosine Kinase Inhibitors on the Cardiovascular System. Society of Hematologic Oncology (SOHO) 2025. September 4, 2025. Publication Status: Published. Article URL: https://doi.org/10.1016/S2152-2650(25)01891-9
Society of Hematologic Oncology (SOHO) 2026 – Clinical Lymphoma, Myeloma & Leukemia (Impact Factor: 2.7)
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Escalation-of-Care Phenotypes and Progressive Inpatient Deterioration in Acute Myeloid Leukemia: A National Inpatient Sample Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Failure-to-Rescue and Critical Illness Phenotypes in Acute Myeloid Leukemia Hospitalizations With Sepsis: A National Inpatient Sample Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: Pending.
Jones DT, Nanda RK, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Hospital Acute Myeloid Leukemia Volume and Inpatient Mortality Among Acute Myeloid Leukemia Hospitalizations With Sepsis: A National Inpatient Sample Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: Pending.
Nanda RK, Jones DT, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Cardiovascular and Treatment Discontinuation Outcomes With Next-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: Pending.
Nanda RK, Jones DT, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Hematologic Toxicity and Treatment Discontinuation With Venetoclax-Based Regimens in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Trials. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: Pending.
Nanda RK, Jones DT, Larson CAJ, Srinivasmurthy R, Ta J, Hussain AA, Hattin R, Nanda A, Desai V, Thein KZ. Pirtobrutinib Following Covalent BTK Inhibitor Exposure in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Pooled Analysis. Society of Hematologic Oncology (SOHO) 2026. September 9, 2026. Publication Status: Accepted. Article URL: Pending.
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2025 – Molecular Cancer Therapeutics (Impact Factor: 5.4)
Jones DT, Hattin R, Ta J, Hussain A, Srinivasmurthy R, Nanda RK, Lam C, Thein KZ. Efficacy of amivantamab in patients with EGFR-mutated non-small cell lung cancer (NSCLC): A systematic review and combined meta-analysis of phase 3 randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-B063
Jones DT, Srinivasmurthy R, Ta J, Nanda RK, Hussain A, Hattin R, Thein KZ. Tolerability and ocular adverse events of datopotamab deruxtecan in advanced cancers: A systematic review and meta-analysis of phase III trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A095
Srinivasmurthy R, Ta J, Jones DT, Hussain A, Hattin R, Nanda RK, Thein KZ. Incidence of gastrointestinal adverse events in advanced or metastatic cancer patients treated with datopotamab deruxtecan: A systematic review and meta-analysis of phase III randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-C055
Srinivasmurthy R, Nanda RK, Jones DT, Khalid T, Ta J, Do K, Hattin R, Hussain A, Myat YM, Bigcas JL, Thein KZ. Risk of immune-related adverse events with immune checkpoint inhibitors in locally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis of randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-C056
Ta J, Nanda RK, Jones DT, Srinivasmurthy R, Hussain A, Hattin R, Lam C, Thein KZ. Incidence of pulmonary and hematologic adverse events in advanced or metastatic cancer patients treated with datopotamab deruxtecan: A systematic review and meta-analysis of phase III randomized controlled trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A141
Ta J, Hussain A, Hattin R, Jones DT, Srinivasmurthy R, Nanda RK, Lam C, Thein KZ. Risk of dermatologic adverse events with amivantamab in EGFR-mutant non–small cell lung cancer: A systematic review and meta-analysis of phase III trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A142
Ta J, Srinivasmurthy R, Jones DT, Khalid T, Hattin R, Hussain A, Do K, Nanda RK, Myat YM, Bigcas JL, Thein KZ. Toxicity profile of immune checkpoint inhibitors in locoregionally advanced nasopharyngeal carcinoma: A meta-analysis of general and hematologic adverse events from phase II and III randomized trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-A143
Srinivasmurthy R, Ta J, Jones DT, Hattin R, Nanda R, Khalid T, Hussain A, Do K, Bigcas JL, Thein KZ. Locoregional toxicities associated with immunotherapy plus chemoradiation in locally advanced head and neck cancer: A systematic review and meta-analysis of phase 3 trials. Molecular Cancer Therapeutics. AACR-NCI-EORTC 2025. Publication Status: Published. Article URL: https://doi.org/10.1158/1535-7163.TARG-25-C057
APP Cancer Research Summit (ACRS) 2025-
Jones DT, Aboaid H, Khalid T, Nanda RK, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Efficacy of Definitive Radiotherapy with Concurrent and Adjuvant Immune Checkpoint Inhibitors in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC). APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.6062
Jones DT, Aboaid H, Hussain A, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Srinivasmurthy R, Thein KZ. Incidence of Venous Thromboembolism (VTE) Events in Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated with Amivantamab: A Systematic Review and Meta-Analysis of Phase 3 Randomized Controlled Trials. APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.12042
Jones DT, Hattin R, Aboaid H, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Srinivasmurthy R, Thein KZ, Htut TW. Incidence of Ocular Toxicities in Patients with Relapsed/Refractory Multiple Myeloma Treated with Belantamab Mafodotin: A Systematic Review and Meta-Analysis of Phase 3 Randomized Controlled Trials. APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.12040
Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Nanda RK, Thein KZ, Htut TW. Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: ashpublications.org/blood/article/144/Supplement%201/7036/526506/Efficacy-of-Isatuximab-Combination-Regimens-in
Jones DT, Khalid T, Aboaid H, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Nanda R, Bigcas JL, Thein KZ. Addition of Immunotherapy to Standard-of-Care Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta-Analysis. APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: Pending
Nanda RK, Jones DT, Srinivasmurthy R, Khalid T, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Efficacy of the Addition of Immune Checkpoint Inhibitors in Patients with Locally Advanced Nasopharyngeal Carcinoma. APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: https://aacrjournals.org/cancerimmunolres/article/13/2_Supplement/B039/751658/Abstract-B039-A-Systematic-Review-and-Meta?searchresult=1
Nanda RK, Jones DT, Khalid T, Srinivasmurthy R, Aboaid H, Ta J, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, Thein KZ. Assessing the Risk of Locoregional, General, Hematological, and Late Adverse Events in Patients with Locally Advanced Nasopharyngeal Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: https://aacrjournals.org/cancerimmunolres/article/13/2_Supplement/B042/751655/Abstract-B042-Assessing-the-risk-of-locoregional?searchresult=1
Nanda RK, Jones DT, Srinivasmurthy R, Aboaid H, Nguyen K, Ta J, Chuang BTM, Myat YM, Thein KZ. Efficacy of Immunochemotherapy in Primary Advanced or Recurrent Endometrial Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials (RCTs). APP Cancer Research Summit (ACRS). September 27, 2025. Poster Presentation. Publication Status: Published. Article URL: https://doi.org/10.6004/jnccn.2024.7330
American Heart Association (AHA) 2025 – Circulation Journal (Impact Factor: 37.8)
Win ZT, Hussain AA, Srinivasmurthy R, Hattin R, Nanda RK, Jones DT, Chu MJ, Ta J, Tun T, Aboaid H, Nguyen KK, Myat YM, Mohib K, Macias A, Htwe KK, Thein KZ. Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to Control. American Heart Association (AHA). November 2025. Publication Status: Accepted for Publication. Article URL:
American Heart Association (AHA) 2026 – Circulation Journal (Impact Factor: 37.8)
Win ZT, Larson CAJ, Hussain AA, Srinivasmurthy R, Hattin R, Nanda RK, Ta J, Chovatiya J, Lin WJ, Jones DT, Htwe KK, Yang EH, Thein KZ. Distinct Inpatient Phenotypes of Transthyretin and Light-Chain Amyloidosis Hospitalizations in the United States: A National Inpatient Sample Analysis, 2017–2023. American Heart Association (AHA). November 2026. Publication Status: Accepted for Publication.
Win ZT, Srinivasmurthy R, Nanda RK, Ta J, Hattin R, Hussain AA, Larson CAJ, Chovatiya J, Lin WJ, Jones DT, Thein KZ, Yang EH. Acute Cardiovascular Decompensation in Renal Cell Carcinoma Hospitalizations: National Inpatient Outcomes and Failure-to-Rescue (NIS 2016–2023). American Heart Association (AHA). November 2026. Publication Status: Accepted for Publication.
American Society for Radiation Oncology (ASTRO) – Multidisciplinary Head & Neck Cancers Symposium 2026 – International Journal of Radiation Oncology • Biology • Physics (Impact Factor: 8.1)
Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Myat YM, Hussain A, Hattin R, Khalid T, Tian S, Shah S, Francis S, Bigcas J, Thein KZ. Differential Efficacy of PD-1 and PD-L1 Inhibitors in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials. American Society for Radiation Oncology (ASTRO) – Multidisciplinary Head & Neck Cancers Symposium. February 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the International Journal of Radiation Oncology • Biology • Physics (Red Journal). Article URL:
Hussain A, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Myat YM, Hattin R, Khalid T, Tian S, Shah S, Francis S, Bigcas J, Thein KZ. Definitive vs Peri-Operative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials. American Society for Radiation Oncology (ASTRO) – Multidisciplinary Head & Neck Cancers Symposium. February 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the International Journal of Radiation Oncology • Biology • Physics (Red Journal). Article URL:
International Academy of Cardiovascular Sciences (IACS-NAS) – Canadian Journal of Physiology and Pharmacology (Impact Factor: 2.273)
Jones DT, Nanda RK, Win ZT, Hussain AA, Hattin R, Srinivasmurthy R, Ta J, Chu T, Tun T, Aboaid H, Myat YM, Nguyen KK, Macias A, Thein KZ, Htwe KK, Htut TW. Atrial Fibrillation Risk with Second-Generation Covalent and Non-Covalent Bruton’s Tyrosine Kinase Inhibitors: A Meta-Analysis of Randomized Controlled Trials. International Academy of Cardiovascular Sciences (IACS-NAS). 2025. Publication Status: Published.
Nanda RK, Jones DT, Win ZT, Hussain AA, Hattin R, Srinivasmurthy R, Ta J, Chu T, Tun T, Aboaid H, Myat YM, Nguyen KK, Macias A, Thein KZ, Htwe KK, Htut TW. Bleeding Risk with Next-Generation BTK Inhibitors: A Meta-Analysis of Randomized Controlled Trials. International Academy of Cardiovascular Sciences (IACS-NAS). 2025. Publication Status: Published.
Win ZT, Hussain AA, Hattin R, Jones DT, Nanda RK, Srinivasmurthy R, Ta J, Chu T, Tun T, Aboaid H, Myat YM, Nguyen KK, Macias A, Thein KZ, Htwe KK, Htut TW. Meta-Analysis of Phase III Randomized Controlled Trials Evaluating the Risk of Cardiac Adverse Events in Patients with Hematologic Malignancies Treated with Acalabrutinib Compared to Control, including BTK Inhibitor (Ibrutinib). International Academy of Cardiovascular Sciences (IACS-NAS). 2025. Publication Status: Published.
Win ZT, Hussain AA, Jones DT, Hattin R, Nanda RK, Srinivasmurthy R, Chu MJ, Ta J, Tun T, Aboaid H, Nguyen KK, Myat YM, Macias A, Thein KZ, Htwe KK, Htut TW. Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Hematologic Malignancies Treated with Acalabrutinib. International Academy of Cardiovascular Sciences (IACS-NAS). 2025. Publication Status: Published.
American College of Gastroenterology (ACG) Annual Scientific Meeting 2026 – American Journal of Gastroenterology (Impact Factor: 10.8)
Sheraz F, Jones DT. Racial, Insurance-Based, and Socioeconomic Disparities in Acute Pancreatitis Outcomes: A Contemporary National Inpatient Sample Analysis, 2016–2023. American College of Gastroenterology (ACG) Annual Scientific Meeting. 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the American Journal of Gastroenterology (AJG). Article URL:
Sheraz F, Jones DT. Trends in MASLD-Related Cirrhosis Hospitalizations and Impact of Metabolic Comorbidity Burden on Inpatient Outcomes in the United States, 2016–2023. American College of Gastroenterology (ACG) Annual Scientific Meeting. 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the American Journal of Gastroenterology (AJG). Article URL:
Sheraz F, Jones DT. Gender Disparities in Inflammatory Bowel Disease Hospitalizations: Outcomes, Complications, and Healthcare Utilization in the United States, 2018–2023. American College of Gastroenterology (ACG) Annual Scientific Meeting. 2026. Publication Status: Accepted for Presentation; Abstract to be Published in the American Journal of Gastroenterology (AJG). Article URL:
American Diabetes Association (ADA) Scientific Sessions 2026 – Diabetes (Impact Factor: 8.4)
Everett J, Chaganal P, Jones DT, Shah P. Diabetes as a Disease-Specific Modifier of Inpatient Outcomes across High-Acuity Medical Admissions: An Analysis of the 2016–2023 National Inpatient Sample. American Diabetes Association (ADA) Scientific Sessions. June 2026. Publication Status: Published. Article URL: https://doi.org/10.2337/db26-2275-P
.
Everett J, Chaganal P, Jones DT, Shah P. Reexamining the Diabetes Paradox: A National Analysis of Hyperglycemia across Acute Cardiovascular and Pulmonary Hospitalizations, 2016–2023. American Diabetes Association (ADA) Scientific Sessions. June 2026. Publication Status: Published. Article URL: https://doi.org/10.2337/db26-2276-P
National American College of Physicians (ACP) 2025-
Jones DT, Nanda RK, Aboaid H, Thein KZ. Post CAR-T Therapy Patient with Haemophilus Influenzae Infection, Bilateral Bronchiectasis, and Pneumothorax: A Case Report. Poster Presentation: National American College of Physicians (ACP) 2025. New Orleans, LA, United States of America; 04/05/2025.
Sadarangani V, Bhagwakar A, Espiritu N, Gandu MS, Jones DT, Nanda R, Xu E. Fruquintinib-Induced Cerebellar Hemorrhage in Left-Sided Descending Metastatic Colorectal Adenocarcinoma: A Case Report and Risk Assessment. Poster Presentation: National American College of Physicians (ACP) 2025. New Orleans, LA, United States of America; 04/05/2025.
Xu E, Jones DT, Deangelo D, Sadarangani R, Bhagwakar A, Espiritu N, Gandu S, Nanda R, Ho L. High-Grade Serous Ovarian Carcinoma with Brain Metastasis: Exploring the Potential of Targeted Therapy. Poster Presentation: National American College of Physicians (ACP) 2025. New Orleans, LA, United States of America; 04/05/2025.
Patil Y, Nanda RK, Venkat H, Espiritu N, Gandu S, Jones DT, Aboaid H, Thein KZ. Myelodysplastic Syndrome with Thrombocytopenia: A Diagnostic and Therapeutic Perspective. Poster Presentation: National American College of Physicians (ACP) 2025. New Orleans, LA, United States of America; 04/05/2025.
Vachirakorntong B, Nanda RK, Jones DT, Aboaid H, Thein KZ. A Rare Case of Mucosal Melanoma of the Hard Palate: Diagnostic Challenges and Treatment Considerations. Poster Presentation: National American College of Physicians (ACP) 2025. New Orleans, LA, United States of America; 04/05/2025.
Durah M, Nanda RK, Jones DT, Aboaid H, Thein KZ. Successful Management of Idiopathic Hypereosinophilic Syndrome with Mepolizumab. Poster Presentation: National American College of Physicians (ACP) 2025. New Orleans, LA, United States of America; 04/05/2025.
Nevada Chapter American College of Physicians (ACP) 2024-
Srinivasmurthy R, Ta J, Jones DT, Pandit M, Thein KZ, Shah AB.. Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL). Oral presentation: Nevada Chapter American College of Physicians (ACP); 10/01/2024. Las Vegas, NV, United States of America
Georgia Chapter American College of Physicians (ACP) 2026-
Taysom C, Larson CAJ, Jones DT, Thein KZ. The Thrombosis–Bleeding Paradox in Colorectal Cancer: Mortality Across Discordant Hemostatic Phenotypes. Presentation: Georgia Chapter American College of Physicians (ACP) Annual Scientific Meeting; 10/09/2026–10/11/2026. Atlanta, GA, United States of America.
Regional American College of Physicians (ACP) 2024-
Ta J, Jones DT, Srinivasmurthy R, Pandit M, Thein KZ, Shah AB.. Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) (Winner). Oral presentation: Regional Nevada Chapter American College of Physicians (ACP); 09/06/2024. Las Vegas, NV, United States of America.
Khalid T, Ta J, Jones DT, Srinivasmurthy R, Thein KZ.. Regional Nevada Chapter American College of Physicians (ACP) Abstract Competitions. Poster presented: Recurrent Extranodal NK/T-Cell Lymphoma of the Nasal Cavity: Diagnostic Challenges and Therapeutic Strategies. Las Vegas, NV, United States of America; 09/06/2024. Khalid
Chaganlal PP, Kalandoor V, Jones DT, Pace C, Silver SA. Regional Nevada Chapter American College of Physicians (ACP) Abstract Competitions. Poster presented: Advanced Calciphylaxis in a Patient With End-Stage Renal Disease: A Case Report Highlighting Diagnostic and Therapeutic Challenges in Late-Stage Presentation. Las Vegas, NV, United States of America; 09/06/2024.
UNLV Medical Student Research Symposium-
T, Ta J, Jones DT, Srinivasmurthy R, Thein KZ.. UNLV Medical Student Research Symposium. Poster presented: Recurrent Extranodal NK/T-Cell Lymphoma of the Nasal Cavity: Diagnostic Challenges and Therapeutic Strategies. Las Vegas, NV, United States of America; 10/05/2024.
Nevada Osteopathic Medical Association (NOMA) 2024-
Jones DT, Srinivasmurthy R, Htut TW, Myat YM, Zaw MH, Thein KZ.. NOMA Research Symposium. Poster presented: Incidence of Pneumonia, Sepsis and Febrile Neutropenia in Transplant-Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Based Combination Therapy: A Systematic Review and Meta-Analysis. Las Vegas, NV, United States of America; 07/25/2024.
Srinivasmurthy R, Jones DT, Htut TW, Myat YM, Zaw MH, Thein KZ.. NOMA Research Symposium. Poster presented: Tolerability in Transplant-Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Based Combination Therapy: A Systematic Review and Meta-Analysis. Las Vegas, NV, United States of America; 07/25/2024.
Nevada Osteopathic Medical Association (NOMA) 2025-
Wynn J, Aboaid H, Khalid T, Jones DT, Nanda RK, Ta J, Srinivasmurthy R, Do K, Nguyen K, Fama K, Aamer S, Myat YM, Bigcas JL, and Thein KZ presented a study titled “Efficacy of Definitive Radiotherapy with Concurrent and Adjuvant Immune Checkpoint Inhibitors in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC)” at the American Society of Clinical Oncology (ASCO) Annual Meeting in May 2025. This work was published in the Journal of Clinical Oncology and highlights the outcomes of combining immunotherapy with standard chemoradiotherapy in LA HNSCC. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.6062
Wynn J, Aboaid H, Hussain A, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, and Thein KZ conducted a meta-analysis entitled “Incidence of Venous Thromboembolism (VTE) Events in Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated with Amivantamab: A Systematic Review and Meta-Analysis of Phase 3 Randomized Controlled Trials”, which was presented at ASCO 2025 and published in the Journal of Clinical Oncology. The study evaluated VTE risk in EGFR-mutant NSCLC patients treated with Amivantamab. Publication Status: Published. Article URL:: https://doi.org/10.1200/JCO.2025.43.16_suppl.12042
Wynn J, Hattin R, Aboaid H, Jones DT, Hussain A, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Srinivasmurthy R, Thein KZ, and Htut TW presented a study titled “Incidence of Ocular Toxicities in Patients with Relapsed/Refractory Multiple Myeloma Treated with Belantamab Mafodotin: A Systematic Review and Meta-Analysis of Phase 3 Randomized Controlled Trials” at the ASCO Annual Meeting in May 2025. This analysis, published in the Journal of Clinical Oncology, quantified the rate and severity of ocular adverse events associated with Belantamab Mafodotin. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.12040
Wynn J, Hussain A, Aboaid H, Hattin R, Schauer S, Schlesinger T, Twells R, Aharonian K, Parto R, Rahmani R, Lambert-Swainston C, Jones DT, Srinivasmurthy R, and Thein KZ authored a study titled “Risk of Pulmonary Toxicities in Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated with Amivantamab: A Systematic Review and Meta-Analysis of Phase 3 Randomized Controlled Trials”, presented at ASCO in May 2025. Published in the Journal of Clinical Oncology, this study focused on evaluating pulmonary adverse effects related to Amivantamab. Publication Status: Published. Article URL: https://doi.org/10.1200/JCO.2025.43.16_suppl.e24035
Touro Research Day 2025-
Ampil A, Nanda RK, Oshiro C, Jones DT, Espiritu N, Aboaid H, Thein K. Tumor-Agnostic Therapy with Trastuzumab Deruxtecan in NRG1-HER2 Fusion-Driven Metastatic Carcinoma. Poster Presentation. Touro Research Day, March 26, 2025.
Bhagwakar A, Nanda RK, Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Thein KZ. Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. Poster Presentation. Touro Research Day, March 26, 2025.
Bhatti M, Nanda RK, Gandu S, Bhagwakar A, Jones DT, Aboaid H, Thein KZ. Post CAR-T Therapy Patient with Haemophilus Influenzae Infection, Bilateral Bronchiectasis, and Pneumothorax: A Case Report. Poster Presentation. Touro Research Day, March 26, 2025.
Durah M, Nanda RK, Jones DT, Aboaid H, Thein KZ. Management of Idiopathic Hypereosinophilic Syndrome with Mepolizumab. Poster Presentation. Touro Research Day, March 26, 2025.
Espiritu N, Nanda RK, Gandu S, Patil Y, Bhagwakar A, Sadarangani V, Xu E, Jones DT. Raoultella Ornithinolytica Urinary Tract Infection in Triple-Negative Breast Cancer. Poster Presentation. Touro Research Day, March 26, 2025.
Hong M, Rubenstein M, Nanda RK, Nguyen K, Srinivasmurthy R, Aboaid H, Jones DT, Ta J, Thein KZ. Meta-Analysis of Phase II/III Randomized Controlled Trials to Determine the Incidence of Hypertension and Proteinuria in Patients with Gastrointestinal Cancers Treated with Fruquintinib. Poster Presentation. Touro Research Day, March 26, 2025.
Irmak I, Nanda RK, Aboaid H, Jones DT, Nguyen K, Srinivasmurthy R, Ta J, Thein KZ. Meta-Analysis of Phase II/III Randomized Controlled Trials to Evaluate the Incidence of Hand-Foot Skin Reaction (HFSR) or Palmar-Plantar Erythrodysesthesia (PPE) Syndrome in Patients with Gastrointestinal Cancers Treated with Fruquintinib. Poster Presentation. Touro Research Day, March 26, 2025.
Meher F, Nanda RK, Espiritu N, Jones DT, Patil Y, Venkat H, Aboaid H, Thein KZ. Multisystemic Complications in Antiphospholipid Syndrome: A Case Report and Overview of Therapeutic Challenges. Poster Presentation. Touro Research Day, March 26, 2025.
Nanda RK, Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Thein KZ, Htut TW. Updated Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Incidence of Pneumonia, Upper Respiratory Tract Infections (URTIs), and Venous Thromboembolism (VTE) in Patients with Multiple Myeloma Treated with Isatuximab.Poster Presentation. Touro Research Day, March 26, 2025.
Oshiro C, Nanda RK, Ampil A, Jones DT, Espiritu N, Aboaid H, Thein KZ. Synchronous Familial Testicular Seminoma: A Rare Case of Two Siblings with Identical Diagnoses. Poster Presentation. Touro Research Day, March 26, 2025.
Rubinstein M, Hong M, Nanda RK, Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Ta J, Thein KZ. Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Hemorrhage and Venous Thromboembolism (VTE) Events in Patients with Gastrointestinal Cancers Treated with Fruquintinib. Poster Presentation. Touro Research Day, March 26, 2025.
Sadarangani V, Nanda RK, Jones DT, Aboaid H, Srinivasmurthy R, Nguyen K, Bhagwakar A, Espiritu N, Gandu S, Xu E, Thein KZ. Updated Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Incidence of Second Primary Malignancies (SPMs) in Patients with Multiple Myeloma Treated with Isatuximab. Poster Presentation.Touro Research Day, March 26, 2025.
Singh R, Nanda RK, Ta J, Aboaid H, Srinivasmurthy R, Nguyen K, Jones DT, Tzer-Ming Chuang B, Myat Y, Thein KZ. A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Hypertension and Proteinuria in Patients with Cancers Treated with Fruquintinib. Poster Presentation. Touro Research Day, March 26, 2025.
Vachirakorntong B, Nanda RK, Jones DT, Aboaid H, Thein KZ. A Rare Case of Mucosal Melanoma of the Hard Palate: Diagnostic Challenges and Treatment Considerations. Poster Presentation. Touro Research Day, March 26, 2025.
Xu E, Jones DT, Deangelo D, Sadarangani R, Bhagwakar A, Espiritu N, Gandu S, Nanda V, Ho L. High-Grade Serous Ovarian Carcinoma with Brain Metastasis: Exploring the Potential of Targeted Therapy. Poster Presentation. Touro Research Day, March 26, 2025.
Regional American College of Physicians (ACP) 2025-
Park S, Tupu M, Awan T, Nanda R, Jones DT, Thein KZ. Novel Combination: Hemoglobin J-Paris-I and Alpha-Globin Duplication in a Patient of Mexican Heritage. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Ramirez YV, Tupu M, Park S, Nanda R, Jones DT, McNamara M, Thein KZ. Relapsed Peripheral T-Cell Lymphoma, TFH Subtype: Recognition, Referral, and Survivorship Care. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Huang B, Lee A, Park S, Nanda R, Jones DT, Thein KZ. Novel Presentation of Ewing Sarcoma/PNET in a Middle-Aged Female: A Case Report. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Lin R, Park S, Tupu M, Awan T, Nanda R, Jones DT, Thein KZ. Metachronous Pleomorphic Sarcomas of Soft Tissue: Two Distinct Primary Tumors in a Single Patient. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Tallman C, Tupu M, Park S, Tahir N, Nanda R, Jones DT, Thein KZ. Provoked DVT in Hypokalemic Periodic Paralysis: A Case Report. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Price Z, Tupu M, Park S, Valle Ramirez Y, Jones DT, Nanda R, Thein KZ. Rare Presentation of Mucoepidermoid Carcinoma of the Buccal Mucosa: A Case Report. Abstract Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Unciano S, Tupu M, Park S, Tallman C, Jones DT, Nanda R, Thein KZ. Refractory Extranodal Rosai-Dorfman Disease: Case Report and Review of Targeted Approaches. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Sigmund J, Park S, Tupu M, Choi K, Eziakonwa A, Nanda R, Jones DT, Thein KZ. Multifocal Combined Hepatocellular-Cholangiocarcinoma Managed with Liver Transplantation and Adjuvant Capecitabine: A Case Report. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Oliver A, Park S, Tupu M, Nanda R, Jones DT, Thein KZ. Extraocular Sebaceous Adenocarcinoma of the Cheek in a Patient with Multiple Primary Skin Cancers: Successful Surgical Management. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Muzzall T, Khavkin B, Tupu M, Park S, Khandadash A, Jones DT, Nanda R, Thein KZ. Acute Airway Obstruction from a Giant Carotid Body Paraganglioma: A Case Report. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
McCormick C, Park S, Tupu M, Nanda R, Jones DT, Thein KZ. Cardiotoxicity of Avelumab: The Importance of Proactive Monitoring for Asymptomatic Myocarditis. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Eziakonwa A, Park S, Tupu M, Awan T, Sigmund J, Nanda R, Jones DT, Thein KZ. Durable Response to Dostarlimab in an 87-Year-Old Patient with MSI-H Cecal Adenocarcinoma. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Khandadash A, Tupu M, Park S, Khavkin B, Tahir N, Shenoy S, Jones DT, Nanda R, Thein KZ, Ho L. Thiamine Deficiency and Wernicke’s Encephalopathy in the Setting of Peptic Ulcer Disease. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Lee A, Park S, Tupu M, Magarin L, Phan Q, Nanda R, Jones DT, Kingsley E. Atypical Presentation of Synchronous Hematologic Malignancy: A Case of Chronic Lymphocytic Leukemia and Multiple Myeloma. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Broome P, Park S, Tupu M, Patel R, Nanda R, Jones DT, Thein KZ. Trastuzumab Deruxtecan’s Efficacy Against Brain Metastases from Salivary Duct Carcinoma: A Case of Adherence and Response. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Ng T, Tupu M, Park S, Unciano S, Nanda R, Jones DT, Thein KZ. Persistent Facial Palsy Revealing AR+/HER2+ Parotid Carcinoma: A Case Report. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Tahir N, Tupu M, Park S, Maldonado N, Nanda R, Jones DT, Thein KZ. Surveillance and Long-Term Care in Grade 2 Meningioma: A Case Report. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Brown J, Park S, Tupu M, Awan T, Nanda R, Patel R, Oliver A, Jones DT, Thein KZ. From Benign to Malignant: A Case Report of Carcinoma ex Pleomorphic Adenoma. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Nanda R, Park S, Tupu M, Awan T, Jones DT, Thein KZ. High-Grade Pleomorphic Liposarcoma in a Patient with Li-Fraumeni Syndrome: A Case Report. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Jayne A, Tupu M, Park S, Tallman C, Nanda R, Jones DT, Thein KZ. Delayed Diagnosis of Dermatofibrosarcoma Protuberans Initially Misclassified as Fibromatosis. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Burrington R, Park S, Tupu M, Awan T, Nanda R, Oliver A, Jayne A, Jones DT, Thein KZ. Rethinking Neutropenia: A Case of Symptom-Free Severe Chronic Neutropenia. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Choi K, Park S, Tupu M, Awan T, Nanda R, Oliver A, Jones DT, Thein KZ. Richter’s Transformation as a Breakthrough Event in a Patient on a BTK Inhibitor. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Tupu M, Park S, Valle Ramirez Y, Unciano S, Jones DT, Thein KZ. Plasmacytoma Mimicking Sarcoma in a Patient with Multiple Myeloma. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Magarin L, Tupu M, Park S, Lee A, Nanda R, Jones DT, Thein KZ. Tumor Rupture and Acute Hemorrhage in Recurrent Laryngeal Spindle Cell Carcinoma. Abstract Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
Nevada Chapter American College of Physicians (ACP) 2025-
Burrington R, Park S, Tupu M, Awan T, Nanda R, Oliver A, Jayne A, Jones DT, Thein KZ. Rethinking Neutropenia: A Case of Symptom-Free Severe Chronic Neutropenia. Poster Presentation: Nevada Chapter of American College of Physicians Regional Poster Competition 2025. Las Vegas, NV; 09/05/2025.
American Society of Anesthesiologists (ASA) – 2026 ASA Anesthesiology National Conference
Khavkin B, Jones DT.. Carotid Body Paraganglioma. American Society of Anesthesiologists (ASA). 2026. Publication Status: Submitted.
American College of Rheumatology Convergence 2026
Tabbah T, Farrukh F, Jones D, Choi J, Farrukh DN, Shah P. Racial and Social Disparities in Inpatient Outcomes Among Adults with SLE: A Nationwide Analysis, 2016–2023. American College of Rheumatology (ACR) Convergence. 2026. Publication Status: Submitted. Submission ID: 2431079.
Congress of Clinical Rheumatology (CCR) West 2025 – North American Young Rheumatology Investigator Forum (NYRIF)
Farrukh F, Tabbah T, Jones DT, Choi J, Shah P. Inpatient Outcomes of Acute Venous Thromboembolism in Systemic Lupus Erythematosus and Vasculitis: A National Inpatient Sample Retrospective Cohort Study. Congress of Clinical Rheumatology (CCR) West 2025 - North American Young Rheumatology Investigator Forum (NYRIF). 2025. Presentation Type: Poster. Publication Status: Accepted.
Farrukh F, Tabbah T, Jones DT, Choi J, Shah P. Paradoxical Cardioprotection in Rheumatoid Arthritis and Psoriatic Arthritis: Demonstration of Berkson’s Bias When Using the National Inpatient Sample, 2016-2023. Congress of Clinical Rheumatology (CCR) West 2025 - North American Young Rheumatology Investigator Forum (NYRIF). 2025. Presentation Type: Oral. Publication Status: Accepted.
Quality Improvement Initiatives
Improving Patient Understanding of Graduate Medical Education Teams and Patient-Experience Scores Through Standardized Bedside Education. Brown L, Bakir R, Kanwal HI, Nichols C, Tupas E, Karki Y, Jones DT, Shah P. Department of Internal Medicine, Sunrise Health GME Consortium, Las Vegas, NV, USA. Prospective six-month quality improvement initiative evaluating standardized bedside education, GME team-role clarification, and preintervention versus intervention-period attending physician PEX scores. Status: Implementation and data collection in progress. Planned presentation: Las Vegas ACP Regional Abstract Competition and Nevada ACP Chapter Meeting.
Editorial and peer review contributions
Invited peer reviewer for:
- JCO Clinical Cancer Informatics
- European Journal of Haematology
- Frontiers in Immunology
- Frontiers in Oncology
- Frontiers in Pharmacology
- Cancer Medicine
- Journal of Inflammation Research
- Frontiers in Bioscience–Landmark
- Clinical Interventions in Aging
- OncoTargets and Therapy
- Journal of Gastrointestinal Oncology
- Cancer Management and Research
- AME Clinical Trials Review
- World Journal of Oncology
Experiences
ASCO-Registered Oncology Student Interest Group (OSIG), Founder and President
Sunrise Health GME Consortium, Las Vegas, NV (2026-Present)
Founded and lead a resident-focused oncology interest group within Sunrise Health GME Consortium
Develop educational programming in hematology, medical oncology, precision oncology, clinical trials, and emerging therapeutics
Coordinate mentorship opportunities connecting residents with practicing hematologists and medical oncologists
Organize oncology research workshops focused on study design, abstract development, manuscript preparation, and national conference submissions
Lead hematology-oncology fellowship and career-development programming for residents interested in oncology
Oversee ASCO Oncology Student Interest Group (OSIG) program participation and annual group activities
Sunrise Health GME Oncology Research Group Founder and President
Sunrise Health GME Consortium, Las Vegas, NV (2025–Present)
Lead research design and execution across internal medicine subspecialties, general surgery, anesthesiology, and OB/GYN residency programs
Conduct statistical analysis, interpret data, and write abstracts and manuscripts
Directed 80+ abstracts submitted to ASCO 2026
Built standardized workflows for high-volume research production
Mentor trainees in study design, statistics, and scientific writing
Coordinate multidisciplinary teams across residency programs
Research Mentorship Las Vegas, NV (2025-Present)
Mentored 50+ medical students and residents in research design, statistical analysis, abstract development, manuscript preparation, and project execution
Mentor trainees from Sunrise Health GME Consortium, Touro University Nevada, UNLV, St. Rose Dominican/Dignity Health, and Valley Health System residency programs
Guide projects from initial concept through national presentation and publication
Assessment of Perioperative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma Using Serial Tumor-Informed ctDNA (Signatera): A Retrospective Chart Review, Co-InvestigatorUniversity Medical Center, Las Vegas, NV (2026–Present)
Retrospective chart review evaluating Signatera ctDNA dynamics and clinical outcomes in locally advanced HNSCC
Contributed to study design, protocol development, IRB preparation, and database development
Assessing treatment response, recurrence, disease-free survival, and overall survival outcomes
CANVAS Study Team (AstraZeneca), Co-Investigator
AstraZeneca / Multicenter Observational Research Study (2026–Present)
Observational study evaluating real-world treatment patterns and clinical outcomes in patients with resectable non-small cell lung cancer (NSCLC)
Collaborate with academic and industry investigators on study design, data analysis, and dissemination of findings
Assess treatment sequencing, perioperative management strategies, and outcomes in contemporary NSCLC care
Tempus Real-World Data Research Collaboration, Co-Investigator
Tempus AI / Vanderbilt University Medical Center (2026–Present)
Collaborate on oncology outcomes research utilizing Tempus clinicogenomic real-world datasets
Conduct statistical analyses evaluating biomarker-driven treatment outcomes and precision oncology strategies
Contribute to abstract, manuscript, and conference presentation development
Jobee Swim, Co-Founder
Las Vegas, NV
Built and scaled an online swimwear store with retail distribution in Las Vegas gift shops, pools, and clubs
Led marketing strategy, influencer partnerships, and operations
Sway Marketing, Co-Founder
Las Vegas, NV
Provide marketing strategy consulting for restaurants, venues, and experiential businesses in Las Vegas
Advise on brand positioning, customer acquisition, and revenue growth strategies
Oversee business operations including pricing, partnerships, and campaign performance
Lead influencer marketing campaigns and manage end-to-end execution
Jones Insurance Company, Founder
Las Vegas, NV
Founded an insurance company offering a range of insurance products
Managed operations, client relationships, and business development
Honors And Awards
2026 Conquer Cancer Merit Award
American Society of Clinical Oncology (ASCO) Early-Onset/Adolescent and Young Adult (EO/AYA) Research Shoutout
2026 Outstanding Author, Translational Breast Cancer Research (TBCR)
Beta Gamma Sigma (BGS) Honor Society, Top 20% of MBA Class, The Johns Hopkins University, 2026
Dean’s Scholarship, The Johns Hopkins University
Harvard University Scholarship, T.H. Chan School of Public Health
Touro University Nevada Dean’s List
Utah State University Dean’s List
Utah State University Scholarship
High School Academic Achievement, 4.0 GPA
Technical Skills
Statistical & Analytical Software: STATA, SAS, R, RStudio
Meta-Analysis & Evidence Synthesis: RevMan
Electronic Health Record (EHR) Systems: MEDITECH, Epic, eClinicalWorks (eClinical), AdvancedMD
Precision Oncology & Molecular Data Platforms: TEMPUS
Certificates
Catalyst Medical Consulting Research Workshop
Harvard Chan Student Organizations
Harvard Chan Computational Biology+ Student Club, Member, 2026-Present
Harvard Chan Pharmacoepidemiology Student Club, Member, 2026-Present
Harvard Chan Public Health Innovation x Technology Student Forum (PHIT), Member, 2026-Present
Harvard Chan Student Government Association - Academic Program Representatives, Member, 2026-Present
Professional Memberships
American Society of Clinical Oncology (ASCO)
American Society of Hematology (ASH)
National Comprehensive Cancer Network (NCCN)
European Society For Medical Oncology (ESMO)
Nevada Oncology Society (NOS)
American Association for Cancer Research (AACR)
American Society for Radiation Oncology (ASTRO)
American College of Physicians (ACP)
American Medical Association (AMA)
American Osteopathic Association (AOA)
Clark County Medical Society (CCMS)
Media/Press Coverage
EastIdahoNews.com
Jones DT. Featured in: Rexburg local wins prestigious award for high-tech cancer research. EastIdahoNews.com. August 29, 2026. Available from: https://www.eastidahonews.com/2026/08/rexburg-local-wins-prestigious-award-for-high-tech-cancer-research/
Translational Breast Cancer Research (TBCR)
Jones DT. Featured in: Interviews with Outstanding Authors (2026). Translational Breast Cancer Research. 2026. Recognized and interviewed as a 2026 Outstanding Author. Available from: https://tbcr.amegroups.org/post/view/interviews-with-outstanding-authors-2026
Harvard T.H. Chan School of Public Health
Jones DT. Featured in: Master of Public Health Program Bio Book, MPH Generalist Cohort 6. Harvard T.H. Chan School of Public Health. 2026. Available from: https://d31hzlhk6di2h5.cloudfront.net/20260730/1c/06/22/ea/1b6ca26c3d5ed21f173e44b5/bio_book_c6.pdf
OncoDaily
Jones DT. Featured in: Daniel Thomas Jones: Honored to Receive the 2026 Conquer Cancer Merit Award. OncoDaily. August 30, 2026. Available from: https://oncodaily.com/voices/daniel-thomas-jones-577829
Jones DT. Featured in: Daniel Jones – DO, MHS: Bridging Clinical Research and Oncology Innovation. OncoDaily. March 2025. Available from: https://oncodaily.com/blog/daniel-jones251443
Jones DT. Featured in: Daniel Jones – DO, MHS: The Power of Research, Resilience, and Mentorship in Oncology. OncoDaily. March 2025. Available from: https://oncodaily.com/blog/daniel-jones-234044
Thein KZ, Jones DT. Featured in: Dr. Kyaw Zin Thein: Championing Oncology Research, Mentorship, and Global Collaboration. OncoDaily. March 2025. Available from: https://oncodaily.com/blog/kyaw-thein-230750
KSL News (K-Salt Lake)
Jones DT. Featured in: Rexburg man wins prestigious award for high-tech cancer research. KSL.com. August 30, 2026. Available from: https://www.ksl.com/article/51617901/rexburg-man-wins-prestigious-award-for-high-tech-cancer-research
Professional Profiles
LinkedIn: https://www.linkedin.com/in/-danieljones/
Google Scholar: https://scholar.google.com/citations?user=vgKujtIAAAAJ&hl=en&authuser=1
ORCID: https://orcid.org/0009-0000-3625-1790
PubMed Author Page: https://www.ncbi.nlm.nih.gov/myncbi/collections/mybibliography/
ResearchGate: https://www.researchgate.net/profile/Daniel-Jones-128?ev=hdr_xprf
Doximity: https://www.doximity.com/cv/daniel-jones
Web of Science ResearcherID: https://www.webofscience.com/wos/author/record/MVU-6774-2025
Reviewer Credits: https://www.reviewercredits.com/user/danielt.jones/
Scopus ID: 59734339800
Loop: https://loop.frontiersin.org/people/3095355/overview
Sci Profiles: https://sciprofiles.com/profile/danieljones
Instagram: https://www.instagram.com/_danieljones/
Semantic Scholar Profile: https://www.semanticscholar.org/author/D.-Jones/2334332076